The role of immunoregulatory cells in healthy and sick African children. by Kiepiela, Photini.
Durban 
1987 
THE ROLE OF IMMUNOREGUIATORY CELLS 
IN HEALTHY AND SICK AFRICAN CHILDREN 
BY 
FOTINI KIEPIELA 
Submitted in partial fulfilment of 
the requirements for the degree of 
OCCTOR OF PHILOSOPHY 
in the 
Department of Paediatrics and Child Health 




The experimental work described in this thesis was carried out in the 
Department of Paediatrics and Child Health, University of Natal, 
Durban, from June, 1982 to June, 1987 under the supervision of 
Professor H.M. Coovadia. 
These studies represent original work by the author and have not been 
submitted in any form to another University. Where use was made of 
the work of others it has been duly acknowledged in the text. 
Selected results from this thesis have been published in scientific 
journals. Research workers who were closely associated in these 
studies are co-authors in these publications. 
iii 
PAPERS 
1. LORI'AN, J.E., KIEPIEIA, P,, COOVADIA, H,M., SEEDAT, Y.K. (1982)
Suppressor cells assayed by numerical and functional tests in




2, KIEPIEIA, P., COOVADIA, H,M., COOARD, P. (1987) T helper cell 
defect related to severity in measles. scand J Infect.· Dis 19 : 
185-192.
3 •. KIEPIEIA; P., COOVADIA, H.M., CCWA.'IID, P., imoHEAD, R., BECKER, 
P.J. (1987) Age-related lymphocyte subp::,pulation changes among 
healthy Africans from birth to adulthood. _Ann Trop Paediatr 
{accepted for publication). 
4, KIEPIEIA, P., COOVADIA, H.M., <:n·7A.'IID, P., ADHIKARI, M,, BECKER, P.J.
(1!:83) Immunoregulatory cells ir;i Nephrotic Syndrome of childhooo 
S Afr J Sci (acc6pted for publication) 
5. KIEPIELA, P., MICHIE, C,A,, COOVADIA, H,M., CC:MAHD, P., WOODHEAD,
R., CO PPAN, R.H., BECKER, P.J. Irnmunoregulatory changes in
single and combined, mild to moderate schistosanal infections in
African children. l. Numerical assays of T cell subsets in
periphera-J. blood and rectal granuloma (submitted for
publication) •
6. KIEPIELA, P., COOVADIA, H.M., rovA.'IID, P., WOODHEAD, R., COOPPAN,
R.H., BECKER, P.J. Immunoreg1dlatory changes in single and 
combined, mild to moderate schistosomal infections in African 
children. 2. Antigen and mitogen induced suppressor and 
proliferative cells in peripheral blood (submitted for 
publication). 




A.A,, MCOSA, A., COOVADIA, H,M., CCWARD, P.
irnmunoregulatory cells in J:X·ID ·and SMA among'
patients J Neurol Sci (accepted for 
A C K N O W L E D G E M E N T S 
I wish to express my gratitude and deep appreciation to my 
supervisor, Professor H. M. Coovadia, who throughout this. 
·study has provided constant guidance and constructive 
criticism. 
My thanks also extend to Professor A. Moosa and Dr.A. Dawood 
for patients with neuromuscular disorders; Dr. R. M. Cooppan 
for patients with Schistosomiasis; Dr. A. Wesley for grading 
the patients' chest radiographs; Dr. M. Adhikari from Renal 
Clinic at King Edward Hospital and Dr. A. Karrim for the 
inclusion of certain subjects from the study on the 
epidemiology of Hepatitis B Virus. 
I am indebted to the following people: Mrs. P. Coward and R. 
Woodhead for help in the load of work; Mr. R. Zulu for full 
blood count results; Dr . P. J. Becker from the Institut� of 
Biostatistics for his advice on statistical methodology; Miss 
M. de Beer also from the Institute of Biostatistics who 
computed all the data and Mrs. H. Smith for her patience in 
the typing of this manuscript. 
To mv wonderful family: my husband, two little girls, my in­
laws and my father for their endless patience, encouragement 









1. Immunophathogenesis of glomerular disease
2. Immunology of nephrotic syndrome




B. Chronic Renal Failure (CRF)
Aim 
summary 






A. Spinal Muscular Atrophy
B. Duchenne Muscular Dystrophy




































































LIST OF ABBREVIATIONS 
- Azobenzenearsonate
- Antibody dependent cellular cytotoxicity
- Allogenic effect factor
- Aantigen
- Antibody independent cellular cytotoxicity
- Antigen induced suppression
- Anti-lymphocyte sert.nn
- B cell differentiation factor
- B cell growth factor




- Circulating irranune complexes
- Cytomegalovirus
- Concanavalin A
- counts per minute
- Chronic Renal Failure
- Colony stimulating factor
- Cerebrospinal fluid
- Cytotoxic T lymphocytes
- Duchenne Muscular Dystrophy
- Dinitro fluorobenzene
- Dinitro phenyl
- disintergrations per minute
- Delayed type hypersensitivity reaction
- Epstein Barr Virus
- Ethylene diamino tetraacetic acid
- Fluorescent activator cell sorter
- Glutamic acid-alanine-tyrosine
- Glutamic acid-alanine
- Glomerular Basement membrane
- Glutamic acid-tyrosine
- Hepatitis B virus
- Hospital control.
HEL - Chicken egg white lysozyme
HRBC - Horse red blcxxl cells
HSF - Histamine induced suppressor factor
IBF - Irnmunoglobulin binding factor
IC - Indian control







- Irnmunoglobulin variable heavy chain
- Interleukin 1
IL-2 - Interleukin 2
IL-B - Interleukin B
Ir - Immune resp:>nse gene
IRSF - Irnmune resp:>nse suppressor factor
KLH - Keyhole limpet haemxyanin
LAK - Lymphocyte activated killer cell
LCM - Lyrnphocytic choriomeningitis virus
LIF - Leucocyte inhibitory factor
LFA-1 - Lymphocyte function associated antigen
LPS - Lip:>p:>lysaccharide
MESA - Methylated bovine serum albumin
M:NS - Minimal change nephrotic syndrane
MHC - Major histocompatibility complex
MIF - Migration inhibitory factor
MIC - Mixed leukocyte cultures
MN: - Mononuclear cells
MRNA - Messenger ribonucleic acid
MS - Multiple sclerosis
WJA - Measles virus antigen
MW - MJlecular weight
NaI04 - Sodium periodate
NK - Natural killer cell
NP - 4-hydroxy-3-nitrophenyl acetyl
NS - Nephrotic Syndrome
OVA - ovalalbumin
PBMN - Peripheral blcxxl mononuclear cells
PFC - Plaque forming cell
pI isolectric p:>ints
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PMA - Phorbol myristate acetate
PMN - Polymorphonuclear leucocytes
PPD - Purified protein derivative
p;m - Pokeweed mitogen
RE - Reticuloendothelial system
RPI - relative proliferation index
SEA - Soluble egg antigen
sos- Sodium dodecyl sulphate p::>lyacrylamide
PAGE gel electrophoresis
SI - Stimulation index
SIF - Suppressor cell indU?tion factor
SIS$ - Soluble irranune suppressor supernatant
SIRS - Soluble irranune resp::>nse suppressor
SK-SD - Streptokinase streptodornase
SMA. - Spinal muscular atrophy
SRBC - Sheep red blood cells
SSF - Soluble suppressor factor
SWAP - Adult worm antigen
Ti - T cell antigen receptor
TLC - T lymphocyte clones
Tcsi - r contrasuppressor inducer
TcsiF - T contrasuppressor indocer factor
Tcse - T contra suppressor effector
'ID - Thymus dependent
TI - Thymus independent
TNBS03 - Trinitrobenzene sulfonic acid sodium salt 
TNP - Trinitrophenyl
TRF - T cell replacing factor
TRF - Thymus replacing factor
W - Ultraviolet light
V - Variable
VPF - Vascular permeability factor
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This chapter will discuss the investigations done on Nephrotic 
Syndrome and Chronic Renal Failure: 
A. A study of numerical and functional measures of cellular immunity
in 68 children (l:x:>th African and Indian) with nephrotic syndrome
compared to age, sex and race matched controls. Further we relate
these imrnunolog ical tests to the clinical problems of relapse,
remission and infection rates.
B. A study of numerical and functional measures of cellular immunity
in 19 adults with chronic renal failure compared to age, sex and
race matched controls.
Sillvt1ARY: IMMUNOREGULATORY CELLS IN NEPHROTIC SYNDRCME OF CHILDHOOD 
Irnrnunoregulatory cells were evaluated by studying lymphocyte 
subpopulations ( identified by E-rosettes, surface irnrnunoglobulin and 
the OKT set of rronoclonal antibodies), functional assay of suppressor 
cells using Concanavalin A (ConA) and rrononuclear cell (MN:) 
transformation by pokeweed mitogen (PWM) in 68 children with nephrotic 
syndrome of different histological types. 
A decreased T4/T8 ratio was the rrost frequent finding but no uniform 
pattern of immunoregulatory abnormalities was detected in the 
different histological groups; the rrost pronounced changes were found 
in Minimal Change Nephrotic Syndrome (K:NS) and Membranous Nephrotic 
Syndrome (NS). The low T4/T8 ratio was due to a significant increase 
in T8+ cell numbers during relapse compared to remission in t-CNS. 
This difference remained when patients with proteinur ia only were 
compared to those in remission in M:NS. When patients in relapse and 
remission were separately compared to matched controls there was a 
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wider range of immunological alterations mainly affecting cell 
profX)rtions including T4/T8 ratio which was significantly decreased 
during both relapse and remission and B cell numbers which were 
decreased in remission. These abnormalities except for the number of 
B cells were transient as they were not detected in those who had been 
in remission for nore than 5 years. 
The numbers of T8+ cells were increased and the T4/T8 ratio and B
cells decreased in Membranous NS, the profX)rtion of T4+ of T3+ cells
were decreased in Proliferative NS and B cell numbers reduced in 
miscellaneous nephropathies. Immunological parameters (apart from B 
cells) were similar in HBsAg carriers without nephropathy as compared 
to those with nephropathy. ConA induced suppression and PWM 
transformation of MNC were normal in nephrotic syndrome. Significant 
correlations were noted between some immunological parameters and the 
relapse and infection rates in M::NS. 
These results suggest that quantitative derangements of immuno­
regulatory cells may underpin abnormalities related to 
immunopathogenesis and susceptibility to infection noted in the 
nephrotic syndrome of childhood. 
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A. NEPHROTIC SYNDRCME
1. Irnmunopathogenesis of Glomerular Diseases
1.1 Immune Conplexes 
In the early 1960' s two· groups of workers led by Germuth and 
Dixon (Germuth 1953; Dixon et al., 1958) established through 
experimental work on the serum sickness rrodel in the rabbit, that 
glomerular lesions were caused by irranunological mechanisms. M:>st 
of these lesions were characterized by the presence of immune 
aggregates either along the capillary walls or the mesangium - a 
picture which is known as immune complex glomerulonephr i tis. 
Activation of complement components would subs�uently indoce 
damage to glomerular structures, resulting in 
glomerulonephritis. 
However, this idea of irranune complexes being deposited from the 
circulation was challenged since it hardly seemed possible for 
macrorrolecules like immune complexes to be able to gain access to 
the glomerular basement membrane (GBM) and be deposited there. 
Other pathogenetic mechanisms for the indoction of irranune complex 
glomerulonephritis have been described (Van Damme et al., 1978). 
1.2 Size, charge and selectivity of the glomerular filter 
The glomerular filter is comprised of the GBM, consisting of type 
IV collagen, laminin and glycoproteins; of fenestrated 
endothelium lined at the luminal side; and of epithelial cells 
with foot processes that make contact with the GBM at the side of 
the urinary space. This filter contains negative charges which 
are present along the cell membranes of epithelial and 
endothelial cells as negatively charged sialoproteins known as 
glomerular polyanions. There are additional negative charges 
which are present diffusely in the laminae rarae of the GBM. 
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These anionic sites have been identified as glycosoarninoglycans 
(Kanwar and Farquhar, 1979). In the filtration process two 
different filtration nodes take place: one according to size 
(Rennke and Venkatachalarn, 1979) and the other according to 
charge (Change et al., 1975). M:>lecules with an effective radius 
of less than 1,8 nm c'an pass the filter unhindered but with 
increasing nolecular . size ttie clearance of the nolecules 
decreases until it is virtually zero at a nolecular diameter of 
4,2 nm. The charge - selective function of the glomerular filter 
resides in the overall negative charge of the glomerular filter, 
which will repel negatively charged rrolecules whereas the passage 
of neutral or nore cationically charged rrolecules is facilitated. 
01 the basis of these data, doubt was raised whether 
macronolecules like immune complexes were able to travel across 
the GBM and be deposited at the epithelial side. 
1. 3 "Fixed" and "Planted" Antigens
Experimental studies on autologous and heterologous immune 
complex glomerulonephritis provided evidence that no circulating 
immune complexes were deposited in the glomeruli, but instead 
were formed locally in the GBM (Van Damme et al., 1978; Fleuren 
et al., 1980b) • GBM antigens are present in an interrupted 
pattern along the epithelial side so that circulating antibody 
directed against GBM antigens was able to bind to these (Couser 
et al., 1978; van Damme et al., 1978). Such antigens have been 
called "fixed antigens". 
Apart from the role of "fixed antigens" other studies have 
demonstrated that antigens which are not related to the GBM could 
also be involved in the in situ formation of glomerular immune 
aggregates. These antigens first bind to the GBM and 
subs�uently react with their specific antibody. Such antigens 
are known as "planted antigens" (Fleuren et al., 1980a) • 
Antigens like ConA have been shown to act as planted antigens 
(Golbus and Wilson, 1979) as well as cationic antigens (Border 
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et al., 1982) which presumably bind to the anionically charged 
sites in the GBM. M:>reover, cationic antil:xxHes act as planted 
nolecules and bind secondarily to their specific antigen which is 
filtered across the GBM (Oite et al., 1982). It is not known 
whether the charge of circulating immune complexes is important 
in localization in the. GBM or in the mesangium (Gallo et al., 
1983). Experimental evidence has shown that glomerular 
localization of circulating immune complexes occurs only in cases 
· of low affinity immune complexes - this could mean that these
immune complexes first dissociate into their constituents and are
then involved in in situ formation in the glorneruli (Steward,
1979).
It is difficult to extrapolate results from animal studies to the 
human situation although they can be used to form a \l.orking 
hypothesis. Several investigators (Naruse et al., 1974; Douglas 
et al., 1981) have been able to detect tubular brush torder 
antige!"ls in glomerular imrnune aggregates in cases of membranous 
glomerulopathy. This ....ould indicate that the pathogenesis is 
similar to that in autologous and heterologous immune complex 
glomerulonephritis. Planted antigens could be important in cases 
of membranous glomerulonephropathy which accompany epithelial 
malignancies or are associated with viral or parasitic 
infections. In these cases tumour antigens or antigens derived 
from the infectious agents have been found in the glomerular 
immune aggregates. In acute post-streptococcal glornerulo­
nephritis it has been shown that in situ formation of immune 
aggregates in the subendotheliurn involves planted antigens (Lange 
et al., 1983) 
1.4 Acute and Chronic Glomerulonephritis 
In acute glomerulonephr itis the antigen is usually of exogenous 
origin eg. post-infectious glomerulonephritis. If the reaction 
of the host has eliminated the antigen then immune complexes will 
no longer be formed either in the circulation or in situ in the 
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GBM, so that the glomerulonephritis will subside and heal. This 
happens in nore than 90% of cases (Potter et al., 1982) • 
However, when the antigen is of endogenous origin because of the 
constant availability of the antigen there is a continuous 
formation of immune complexes and conse:;iuently results in chronic 
glomerulonephritis. It .has been shown that in 20% of cases with 
chronic glomerulonephritis (Row et al., 1975) there is a 
spontaneous healing. In this type of situation one has to assume 
·that either the immune reaction of the host has subsided or that
the antigen is no longer available. Chronicity of
glomerulonephritis, can also result from immune complexes other
than those originating from antigens from the infectious agent
concerned. It has been shown that acid eluates of glomeruli from
patients with post-streptococcal glomerulonephr i tis contain
anti/IgG antibodies (M:Intosh et al., 1978). In cases of serum
sickness glomerulonephritis, immune aggregates have been removed
from the glomeruli using injections of excess antigen during the
first weeks of the disease (Mannik and Striker, 1980; Haakenstud
et al., 1983), but later excess antigen no longer removes the
aggregates (Penner et al., 1982). When an excess of rheumatoid
factor was used (Rose and Lambert, 1980) , the immune aggregates
disappeared suggesting the presence of IgG-anti-IgG immune
complexes. This might be happening in some cases of chronic
glomerulonephritis which are associated with systemic lupus
erythematosous (SLE) where these anti-idiotypic antibodies might
interfere with the prodoction of antibodies.
Therefore in summary: the pathogenic mechanism in the formation of in 
situ aggregates in immune complex glomerulonephritis appears to be in 
the fixed (GBM) or planted (non-GBM) antigens, although the 
participation of idiotype-anti-idiotype irranune complexes must also be 
considered. The deposition of immune complexes from the circulation 
does not seem to be an important pathogenic mechanism. 
380 
2. Immunology in Nephrotic Syndrome
It is generally accepted that the central abnormality in the nephrotic 
syndrome, irrespective of the cause, is an increase in glomerular 
permeability to protein. The resulting proteinuria, if not 
compensated for by increased protein synthesis, results in reduced 
concentrations of a variety of . plasma proteins. An obvious 
explanation is the readily apparent lesions due to glomerular injury 
seen in renal biopsy material. However, in patients with minimal 
change nephrotic syndrome (M:NS), such lesions are absent. The 
primary defect in this disease is thought to be the immune system; the 
release of a lymphokine may be responsible for the increased 
permeability of the glomeruli to albumin as well as for some of the 
extrarenal abnormalities in M:NS (Figure 75). 
Evidence has shown that T cells are important in pathogenesis 
(Shalhoub, 1974; Mallick, 1977; Schulte-Wisserman, 1977). Shalhoub 
(1974) was the first to postulate that the disease could be produced 
by a systemic abnormality of T cell function. This hypothesis has 
been supported by the following observations: 
{a) There is a dramatic remission of MCNS indu::ed by measles virus, 
which is known to cause immunodepression 
{b) Drugs, such as steroids and cyclophosphamide, that are known to 
depress 01I responses, are of therapeutic benefit {Grupe, 1979) 
{c) An increased susceptibility of M:NS to develope pneurnococcal 
infections 






In 1975, evidence was provided for the hypogarnmaglobulinaemic state 
seen int-CNS (Giangiacomo et.al., 1975). These authors proposed that 
this -was linked to abnormal immune circuits, suggesting a defect at 
the stage of prodoction rather than due to urinary losses. Deereased 
levels of serum IgG and increased levels of IgM in MCNS in relapse has 
been found by several authors (Gupta and Yuceoglu, 1985; Fodor et al., 
1982; Shakib et al., 1977; SObel et al., 1976). The ability of 
lymphocytes to prodoce immunoglobulins when stimulated with PWM in 
vitro, was similarly found to be decreased in patients with membranous 
glomerulonephritis (OOi et al., 1980). In another study Heslan 
et al., (1982) showed that in 4 categories of patients with nephrotic 
syndrome viz. MCNS in remission or relapse, in mernbr anous 
glomerulonephritis and membranoproliferative -glomerulonephritis, MCNS 
patients in remission had in vitro IgG prodoction and serum IgG close 
to normal levels in contrast to the other 3 nephrotic groups which had 
decreased in vitro prodoction of IgG, even though all groups were 
comparable in terms of serum albumin, serum proteins and proteinuria. 
This, the authors suggested to indicate that the 
hypogammaglobulinaemia in nephrotic patients was linked to a synthetic 
deficiency rather than to increased catabolism or urinary losses. 
Although there was this transitory dysfunction of polyclonal B cell 
activation correlating to the state of the nephrotic syndrome, the 
precise localization of the defect and the pathogenic mechanism still 
have to be elocidated. 
(ii) Complement
Wherever, antigen-antibooy complexes initiate local disease, a number 
of other mechanisms are involved in the mediation of a lesion. These 
include the coagulation and the complement system, the release of 
leukotoxins, anaphylatoxin and histamine from leucocytes and/or 
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platelets. In p::>st streptoccoccal glomerulonephritis, it has been 
shown that the complement system is usually activated via the 
alternate pathway as reflected by decreased properdin and C3. 
However, early in the course of p::>st streptococcal glomerulonephritis, 
serum C4 may also be reduced, indicating participation of the 
classical pathway. Reduced plasma C3 levels have also been found in 
nephritis of SLE and low plasma levels of complement may be found in 
membranoproliferative glomerulonephritis (Earle and Jennings, 1966). 
b) Cell mediated Immunity
Recent evidence has shown that irranunoregulatory cells both in number 
(Feehally et al., 1984; Tanphaichitr et al., 1980; Lin, 1985; 
Matsumoto et al., 1984a) and/or function may be abnormal in nephrosis 
(Gupta and Yuceoglu, 1985; Taube et al., 1984; Matsumoto et al., 
1984b; Wu and Moor thy, 1982)) • However, these studies have been 
mainly confined to those patients with MCNS both in adults and 
children, or to other histological categories of nephrotic syndrome 
mainly in adults. 
(i) Numbers of cells
In children with M:NS, several groups of workers (Fodor et al., 1982; 
Kerpen et al., 1979; Herrod et al., 1983) found normal prop::,rtions 
and/or absolute numbers of T cells (E-rosette) in those who were in 
remission as well as in relapse. Tanphaichitr et al., (1980) found a 
decreased percentage of T cells (E-rosette) during relapse. However, 
this discrepancy in the results could be due to the fact that in the 
latter authors', the children in relapse had had prolonged treatment 
with steroids and cyclophosphamide-drugs known to decrease T cell 
number. 
No significant changes in the prop::,rtions of Tj.,L and T� have been found 
in the active stage of M:NS (Gupta and Yuceoglu, 1985). This is in 
contrast with an increase in the mnnbers of OKT3+, OKT4+ and OKT8+
cells with a decrease in 0KT4/0KT8 ratio in �CNS patients in relapse 
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(Feehally et al., 1984), although in MCNS patients in remission normal 
numbers were found. The increase in OKT8+ cells in acute phase MCNS 
has also been demonstrated by Lin (1983). 
(ii) Function of cells
Delayed Hypersensitivity skin reactions 
No differences were found in skin reactions to purified protein 
derivate (PPD) and streptokinase streptodornase (SK - SD) in 
children with MCNS either in remission or relapse or the control group 
(Fodor et al., 1982). However sensitization to dinitrochloro benzene 
(DNCB) was positive in all M'.:NS patients in remission and 93% of 
control children as compared to only 38% in MCNS patients in relapse 
(Fodor et al., 1982). Similar results were observed in adults with 
lipoid nephrosis (Matsumoto et al., 1981). The inability to become 
sensitized to a new T cell-dependent antigen was suggested to imply an 
alteration in the recognition of antigen and/or processing. 
Lynphocyte Transformation to PHA and PPD 
Lymphocyte transformation to PHA was significantly reduced in M'.:NS 
patients in relapse when corrpared with patients in remission and 
control children (Fodor et al., 1982; Gupta and Yuceoglu, 1985). 
Similarly in MCNS patients in relapse who also have a positive skin 
test to PPD, lymphocyte transformation to PPD was reduced in 
comparison to MCNS patients in remission with a positive skin test who 
had normal lymphocyte reactivity. These observations have been 
confirmed in ooth children (Fodor et al., 1982; Martini et al., 1981; 
Inoue et al., 1982) and adults (Iitaka and West, 1979; Sasdelli 
et al., 1980; M:>orthy et al., 1976b). 
It has also been shown that sera from MCNS patients (ooth children and 
adults) in relapse inhibit the normal lymphocytes' response to 
mitogens (Fodor et al., 1982; Inoue et al., 1982; Martini et al., 
1981; Beale et al., 1980; Iitaka and West, 1979; Sasdelli et al., 1980 
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and Taube et al., 1981a). This inhibitory effect is not confined to 
r.KNS, as it has been found in other disorders causing the nephrotic 
syndrome eg. focal glomerulosclerosis and membranous nephropathy 
(Ii taka and West, 1979; Beale et al., 1980; Taube et al., 1981a) • 
Several factors were thought to cause this inhibitory effect of plasma 
from r-KNS patients viz: 
hypoalbuninenia. However · plasma from patients in complete 
remission in which the albumin deficit has been corrected still 
showed an inhibitory effect (Taube et al., 1981a; Fodor et al., 
1982). 
Increased serum concentration of very low density lipoproteins 
(Chisari, 1977; Menchaca and Lefkowitz, 1980). These authors 
observed a decreased lymphocyte transformation response to PHA when 
J.'.CNS patients' lymphocytes in remission were cultured with pooled 
normal serum to which they had added very low density lipoprotein 
fraction to equal the usual nephrotic levels. 
Diminished zinc levels in the hair and plasma has been reported in 
M:NS (Reimold, 1980). There is increasing evidence of the 
involvement of this element in the immune response (Bach, 1981) 
especially for the activity of serum thymic factor (Dardenne 
et al., 1982). Bensman et al. (1984) have reported a diminution in 
the biological activity of serum thymic factor secondary to zinc 
deficiency in children with nephrotic syndrome. 
T suppressor cell activity 
The finding of increased suppressor cell activity (Schulte-Wisserman 
et al., 1977) is not consistent, as a decrease in ConA inducible T 
suppressor cell activity has also been reported in M:NS patients in 
relapse (Gupta and Yuceoglu, 1985; Taube et al., 1984). 
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Vascular Perrreability Factor and other Lyrrphokines 
The mechanisms of glomerulopathy given above do not explain all the 
varieties of glomerulopathy and the occurrence of proteinuria. This 
is the case, especially in MCNS where the absence of significant 
pathologic lesions contrasts with the intensity of the clinical 
symptoms. It could be that other mechanisms of immunologic.origin eg. 
release of hurnoral or cellular mediators could affect the capillary 
permeability independently of the presence or absence of histologic 
injury (Lagrue et al., 1975). It has been shown that a lymphokine 
termed vascular permeability factor (VPF) is released when peripheral 
lymphocytes of patients with nephrotic syndrome are treated by 
concanavalin-A (Sobel and Lagrue, 1980). These authors proposed that 
VPF may participate in the pathogenesis of functional and/or lesional 
alterations in the filtration barrier. It could be that there is an 
abnormal function or elaboration of interleukins in the nephrotic 
syndrome. The finding of an abnormal in vitro B cell activation in 
nephrotic syndrome may illustrate this concept (Heslan et al., 1982). 
VPF has been shown to be abnormal in patients with nephrotic syndrome 
both by in vivo (Sobel and Lagrue, 1980) and by in vitro (Sobel and 
Lagrue, 1980) techniques. All types of nephrotic syndrome had 
increased VPF prodoction (M:NS, focal glomerulosclerosis, membranous 
glomerulonephritis, rnernbranoproliferative -glomerulonephritis) as 
compared to MCNS in remission who had similar values to normal 
controls. (Sobel and Lagrue, 1980). The physicochemical 
characterization of VPF has shown that it is recovered in a peak 
emerging immediately after cytochrome C (rrolecular weight 12700), is 
sensitive to pepsin, resistant to DNAase and RNAase, heat labile at 
100°c and is produced by T cells only (Sobel et al., 1983). 
3. The Nephrotic Syndrome among children in Africa
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The following histological categories of nephrotic syndrome are found 
in Indian and African children in South Africa. 
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steroids (97% of those 
with minimal change 
respond to steroids) 
28% 
Excellent 
Table 48 Histological categories of nephrotic syndrome in Indian 
and African children in South Africa 
N:> obvious lesions: 













In the vast majority of non-African children nephrotic syndrome is not 
a serious disease, there is a predictable response to drug therapy and 
the disease is dominated by minimal change lesions which account for 
+80% of all children with nephrosis (Coovadia and Adhikar i, 1982).
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The nephrotic syndrome in Indian South African children resembles that 
of children in the West, Asia and South America. However in African 
children in Southern Africa, there is an unusual distribution of the 
histopathological types of nephrotic syndrome (Coovadia et al., 1979). 
Table 47 demonstrates the features of nephrotic syndrome in South 
African children. It shoulq be noted that White children with 
nephrotic syndrome in South Africa follow a pattern similar to the 
Indians. 
Even in the absence of the damaging effects of malaria on the kidney, 
African children in Southern Africa have an unusual distribution of 
histopathological types of nephrosis which distinguishes them from 
children in tropical Africa and in other continents. The disease 
behaves differently in African children generally compared with nost 
non-Africans. HBs carrier status is the nost frequent association 
with membranous nephropathy. (Table 47) 









+ve somiasis Mala(ia Typhoid TB 
M:NS African Male 2 1 0 0 0 0 
Female 3 0 0 0 0 0 
Indian Male 20 0 0 0 0 0 
Female 7 0 0 0 0 0 
Membranous African Male 13 12 3 0 0 1 
Female 1 1 1 0 0 0 
Indian Male 0 0 0 0 0 0 
Female 0 0 0 0 0 0 
Proliferative-African Male 4 0 1 0 0 0 
Female 0 0 0 0 0 0 
Indian Male 4 0 0 0 0 0 
Female 3 0 0 0 0 0 
Other African Male 2 1 1 0 1 0 
Female 4 1 0 0 0 0 
Indian Male 5 0 0 0 0 0 
Female 0 0 0 0 0 0 
1) Materials and Methods
Patients and Controls (Table 48) 
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Sixty-eight African and Indian children with NS were studied (Table 
49 ) • Thirty-two children had M:NS . (mean age 8, 20 ±. 0, 71 years, age 
range 1, 75 - 18 years) and of . these 16 were in remission and 2 were 
African. Fourteen children (all African) had Membranous 
Glomerulonephritis (mean age 7, 29 + 0,72 years, Range 4-10 years) of 
whom l was in remission; 13 of these patients were HBsAg carriers; 11 
children had Proliferative glomerulonephritis (mean age 8,81 ±. 1,18 
years, Range 3-13 years) of whom 3 were in remission; 11 children had 
miscellaneous histological groups of NS (mean age 8,99 ±. 1,4 2 years, 
Range 2,92-18 years), of these, 2 were in remission. In each group 
there were rrore males than females. All were biopsy proven except for 
2 patients in the miscellaneous group. None of the patients were in 
chronic renal failure, had elevated serum creatinine levels or had any 
other chronic disease other than the nephrotic syndrome. The HBs 
antigen positive patients did not have liver disease but were 
carriers. None were on any steroid therapy at the time or 6 rconths 
prior to these investigations. Each patient was age, sex and race 
matched with a normal healthy control; these were obtained from a 
comrnuni ty based study of HBV prevalence. (See Chapter on Normal 
development of Immune Response) Eight African children of whom 6 were 
male (age range l year 5 rconths - 10 years) who were HBs antigen 
carriers without nephropathy were used as additional controls for the 
Membranous group. Informed parental consent was obtained in each 
case. 
Definitions used: 
Nephrotic syndrome was defined according to three essential criteria: 




Relapse was defined as the presence of all three features of nephrotic 
syndrome (remission was defined as the absence of all three features 
of nephrotic syndrome), partial remission was defined as the presence 
of persistent proteinuria without oedema and is inclooed under relapse 
for purposes of this study. Partial remission was at times included 
with relapse but this will always be indicated in the text (this was 
done because little differeqce was found in immunological. parameters 
between partial remission and r�lapse). 
The clinical features of protein-energy-malnutrition were absent on 
clinical grounds and according to anthropometric measurements of the 
National Centre for Health Statistics (NCHS) standards of 
weight-for-age, height-for-age and weigtlt-for-height ratios in l::oth 




(i) T and B subpopulations
(This was undertaken as described under Methods)
(ii) T cell subsets using rronoclonal antil::odies.
(This was undertaken as described under Methods)
(B) Functional Assays
(i) T suppressor cell function using ConA pretreatment.
(This was undertaken as described under Methods)
(ii) MNC PWM stimulation
(This was undertaken as described under Methods)
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II Clinical Investigations 
The following clinical features were observed simultaneously (at 
the time of bloodtak ing) : the degree of oedema, hypertension 
haematur ia, albuminur ia; the levels of serum albumin, blood 
cholesterol and ot:. 2-glo�ulin were measured; the status of HBs
antigenaemia was similarly measured; therapy (previous and 
present) as well as the length of the condition with the nLDnber of 
previous mild and. severe infections were noted. Other clinical 
investigations included were to detect schistosomiasis (l::oth 
s.mansoni and S.haematobium), malaria, typhoid and tuberculosis
(TB) • The latter 4 investigations were done only if they v,ere
necessary.
Statistical Analysis 
Results were analysed according to the non-parametric procedures using 
the Mann Whitney U. Results were significant at the 5% level. 
Correlation analysis was performed by using the Pearson correlation 
co-efficient at the 5% level of significance. 
RESULTS 
The results will be discussed as follows: 
A. Effect of Relapse versus Remission
Comparison of Immune parameters in Relapse with those in Remission 
in M:NS patients. 
B. Effect of Histological Differences
Immune parameters among children in different histological groups 
compared to their matched controls. 
c. Effect of Treatment on the Irranune Response
Effect of Previous Treatment 
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All patients (regardless of histology and clinical condition) 
previously treated with prednisone were compared to those who had 
p�eviously been treated with prednisone + cyclophospharnide + 
chlorarnbocil. 
D. Residual Effects after Prolonged Remission
The long term change in irranunological parameters among children in 
remission. 
(a) All patients in remission (regardless of histology) who had
been in remission for m:>re than 5 years were compared to
those who had been in remission for less than 5 years.
(b) Patients with M:NS in remission ·for less than 5 years were
compared to those M:NS patients in remission for rrore than 5
years.
E. The effect of Nephrotic Syndrorre on the Immune Response
All nephrotic syndrome patients were compared to age, sex and race 
matched controls. 
F. Relationship between Relapse and Irranunological Indices and
Infection and Imunological Indices
a) An index of infection was obtained for all nephrotic
syndrome patients:
Index of= Number of previous infections (severe and/or mild); per patient
Infection Length of time of nephrotic syndrome 
This index of infection was then related to certain irranunological 
parameters. 
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b) An index of relapse was obtained for all nephrotic syndrome
patients:
Index of relapse = Number of previous relapses 
Length of ttme of �ephrotic syndrome 
I per patient 
This index of relapse was then related to certain irnmunoogical 
parameters. 
G. Correlations of tests
Correlations were sought between nurner ical and functional assays 
of supression and MtC PWM stimulation within each histological 
group of the nephrotic syndrome. 
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RESULTS 
Note: Not all tests could be performed on all patients, the exact 
number studied is given in the tables. Correlations between immune 
parameters and disease stage ( ie.. remission or relapse or partial 
remission) could only be done ·tor patients with M:NS as there were too 
few patients in _remission in the other histological groups. 
The Indian patients were compared with 25 controls who were in the 
same age range (3-18 years). The African patients were age and sex 
matched with corranuni ty control children undergoing an 
epidemiological study on the prevalence of HBV (see Chapter on 
Normal Developnent of Immune Response). 
A.l. Comparison of Irranune Parameters in Relapse+ Partial Remission
with those in Remission in M:NS Patients (Table 49, Figure 76; 
see appendix table 7 for details) 
M:NS patients in relapse had significantly increased a�solute 
nononuclears, T cells (E-rosette) comprising mainly OKT8 cells 
and a lower T4/T8 ratio compared to those in remission. No 
significant differences were observed with respect to Band Null 
cells, ConA induced suppression and MNC PWM stimulation between 
patients in relapse versus those in remission 
A.2. MNCS Remission versus MNS Partial Remission (Table 50)
This comparison was made to determine at which end of the 
spectrum "partial remission" was situated, viz. towards 
remission or relapse. This could only be done in MCNS as there 
were too few patients in the other histological groups. 
Immunological Parameters 
The number of absolute mononuclear cells, T cells (E-rosette and 
OKT3 r-bAb) comprising mainly OKT8+ cells were significantly 





proportions of T4+ cells of T3+ cells were significantly lower 
in the former. No significant differences were observed with 
. respect to B and Null cells, ConA induced suppression and Mt-X::: 
PWM stimulation between patients in partial remission versus 
those in remission. 
A.3. M:NS Partial Remission versus M:NS Relapse
Immunological Parameters (Table 51) 
No significant differences were found in any of the 
immunological parameters studied between children in partial 
remission compared to those in relapse. 
B. Irranune Parameters arrong children in different histological groups
compared to matched Controls
(Table 52) 
B.l Controls versus M:NS in Remission (Table 52, Figure 77; see
appendix table 8 for detqils) 
r-K:NS children in remission had a significantly increased 
percentage OKT8+ cells of OKT3+ cells, significantly decreased 
0KT4/0KT8 raio and numbers of B cells, compared to their 
respective controls. 
B.2 Controls versus M:NS in Relapse and Partial Remission (Table 52,
Figure 78; see appendix table 8 for details) 
M:NS children in relapse had a significant decrease in percentage 
OKT4+ of OKT3+ cells and in 0KT4/0KT8 ratio as compared to their 
respective controls. Tests were similar in those with 
proteinuria only (partial remission) and those with oedema in 
addition (relapse). 
B.3 Controls versus Membranous (Table 52, Figure 79; see appendix
table 9 for details) 
Children with membranous NS had significantly elevated numbers of 
absolute rrononuclears, T cells (E-rosette and 0KT3 r-DAb) and 
OKT8+ cells with a significantly lower number of B cells and 
0KT4/0KT8 ratio as compared to controls. These children, with 
one exception, were studied in relapse. 
B.4 Controls versus Proliferative (Table 52, Figure 80; see appendix
table 10 for details) 
In the proliferative group the proportion of OKT4+ of OKT3+ cells 
were significantly decreased as compared to controls; this 










ABSOLUTE VALUES FOR LYMPHOCYTE SUBSETS IN HBs ANTIGEN CARRIERS WITH AND WITHOOT 
NEPHROPATHY 
Irranunological Parameters Without 
nephropathy 
Absolute rrononuclears (cells/rnm3) 3611 + 424° 
T cells (E-
3
osette) 2080 + 285 
( ce lls/rran ) 
B cells (Sig+) (cells/rran3) 457 + 105 
Null cells (cells/rran3) 1116 + 214 
'Ibtal T cells (OKT3) (cells/rran3) 2203 + 330 
T helper/indu::er (OKT4) (cells/rran3) 1372 + 258 
T suppressoricytotoxic (OKT8) 1050 + 165 
(cells/rran ) 
% OKT4 of OKT3 
% OKT8 of OKT3
Ratio OKT4/0KT8 
0 =Mean + SEM 
64 + 8 
49 + 5 
1,42 .:t_ 0,23 
With 
nephropathy 
4387 + 432 
3010 + 463
190 + 38 
11178 + 185 
2691 + 319 
1345 + 172 
1448 + 214 
51 + 4 
54 + 6 
1,05 + 0,14 













o. The long term change in irranunological parameters among M:NS
children in Remission (Table 54, Figure 81; see appendix table 12
for details) 
Children with M:NS who had been in remission for longer than 5 
years had significantly lower absolute rrononuclear cells, T cells 
(E-rosette and 0KT3 M::>Ab) compr �sing mainly of OKT8+ .cells than 
children in remission for. less than 5 years. No significant 
d.ifferences were observed in B, Null and OKT4+ cell numbers,
proportions of OKT4+ and OKT8+ cells of OKT3+, 0KT4/0KT8 ratio,
ConA inducible suppression and PWM stimulation between the two
groups. When M:NS children in remission for longer than 5 years
were compared to age, sex and race matched controls, the only
abnormality detected was a significant decrease in the B cell
numbers in the former.
TABLE 54 LONG TERM CHANGE IN IMMUNOLOGICAL PARAMETERS AMONG CHILDREN IN REMISSION 
Lymphocyte subpopulations as T cell subsets as defined by Positive cells as 
defined by E-rosette and Sig Monoclonal antibodies 1 of OKT3 
Period of Abs.mono- T cells B cevs Null Ratio 
Group N Remission nuclears (E-rosette (Sig) cells OKT3 OKT4 OKT8 OKT4 OKT8 OKT4/0KT8 
( u .. ,. .... \ 
MCNS 4 ,5 5255!°1063
° 4014!°1180 235!°38 1533!°259 2801!°481 1488!°299 1698!343 53 ! 7 61 ! 7 0,95!°0,20 
12 >5 2988! 218 1679! 158 162!54 959!141 1666!°187 1017!112 823! 80 62 ! 4 51 ! 2 1, 26!°0, 11 
p value 0,0393* 0,0180* 0, 1763 0,0910 0,0393* 0, 1456 0,0109* 0,2747 0, 1619 0,3023 
Contra ls .6. 12 3145±286 1911±276 415±80 809*114 1744±175 1206*123 821±106 69 ± 3 47 ± 3 2±0, 12 
p value 0,7728 0,5529 0,0176* 0,5978 0,5066 0,2253 0,9540 0,2850 0,2029 0, 1489 
0 Mean± SEM 
* Probability Value f O, 05
A Comparison: Controls versus MCNS (::>5)
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E. Comparison of all nephrotic syndrome patients (regardless of
histology and clinical condition) with age, sex and race matched
controls (Figures 82-87; see appendix table 13 for details)
,,i::c, absolute rononuclear cells, T cells (E-rosette), T cells 
(0KT3MoAb) , T suppressor/cytotoxic cells and the percentage of 
OKT8+ of OKT3+ cells and percentage rnonocytes were significantly 
higher in patients with· nephrotic syndrome as compared to 
controls. However, B cells (Sig), percentage T4 of T3, 0KT4/0KT8 
ratio, T suppressor cell function (using both suboptimal and 
optimal doses) and percentage lymphocytes were significantly lower 
in nephrotic syndrane patients compared to controls. No
significant differences were observed between patients and 








F. Relationship of Infection on the Irronune Response
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An index of infection was obtained for all nephrotic syndrome patients 
according to histology where: 
Index of Infection = Number of previous infections (severe and/or mild) /per patient
Length of_ time of nephrotic syndrome 
This index of infection was related to certain immunological 
parameters. 
Note: Table 55 indicates which infections were classified as mild or 
severe. 
F.l Irronunological Parameters (Figures 88-89)
In M:NS the index of mild infection was significantly p::>sitively 
correlated to the number of: white cells (r=0,572 �0,001); and T 
cells (E-rosettes) (r=0,389 p=0,049). In the membranous, 
proliferative and miscellaneous groups of nephrotic syndrome none 
of the immunological parameters studied were related to any 
indices of infection ie mild or severe alone or combined. The 
index of infection did not correlate with certain clinical 
parameters such as oedema and serum albumin for any of the 
histological groups studied. 
F. 2 An index of relapse was obtained for all nephrot ic syndrome
patients according to histology where: 
Index of Relapse =  Numbe� of previ
ous relapses I per patient 
Lengt of nephrotic syndrome 
This index of relapse was related to certain immunological 
parameters. 
F.3 Irronunological Parameters (Figures 90-92)
The index of relapse in M:NS, was significantly fX)Sitively 
correlated to the numbers of: White cells (r=0,634 p=0,001); 
Null cells (r=0,524 p=0,005); and T suppressor cytotoxic cells 
(r=0,443 p=0,013). In the membranous, proliferative and 
miscellaneous types of nephrotic syndrome, none of the 
imnunological parameters studied related to the index of 
relapse. 
Table 55 








Peritonitis (either pnet.nnoccocal 
or pseudornonas or both) 









Upper respiratory tract infection 
Impetigo 
scabies 
S.haernatobiurn in the urine
'Ibnsilli tis 
Pyoderma 









G. correlations of tests
G. l Correlations between m.uner ical and functional assays of
suppression and MNC � stimulation within each histological 
group of nephrotic syndrome were sought. 
G.1.1 Immunological Parameters·
No correlations were observed between: 
(a)the number of OKT8+ cells and percentage T cell suppression both by
ConA Spg and ConA 3apg/2Spl/ml of cells;
(b) the number of OKT4+ cells and MNC PWM stimulation;
(c) the OKT4/0KT8 ratio with percentage T cell suppression both by
ConA Spg and ConA 30pg/2Spl/ml of cells;
(d) the OKT4/0KT8 ratio with MNC PWM stimulation;
for any of the histological groups of nephrotic syndrome. 
Surranary of Findings (Table 56) 
A. The Effect of Remission versus Relapse in M:NS
1) Children in relapse had reduced T4/T8 ratio due to increased T
cells comprised of T8+.
2) Partial remission was similar to relapse.
B. The Effect of different histolical groups on Immune response
1) A reduced T4/T8 ratio was found in two of the histological types
viz. MCNS and Membranous NS.
2) Immunoregulatory cells are abnormal not only in M:NS but also in
other histological types of nephrosis.
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3) No differences were detected when controls or HBs antigen carriers
with no renal disease were independently compared to membranous
nephrotic syndrome.
c. The Effect of Previous Treatnent
Cnly one patient had been previously treated with P + C + C, hence 
cornpar isons with patients previously treated with P alone could 
not be done. 
D. The long term effect amng children in remission
There was gradual redu::tion in TB+ cell numbers and persistence of 
B cell lymphopenia after 5 years of remission. 
E. The Effect of Nephrotic Syndrorre on the Immune Response
1) Patients with nephrotic syndrome considered as a group had
abnormalities in imrnunoregulatory cell numbers and function.
2) This is a T cell defect due mainly to T suppressor cells.
F. Relationship of Infection on the Irranune Response
Indices of previous mild infections and relapses were related to 
inmune deficiencies , particularly int-CNS. 
G) Correlation of Tests




It is widely believed that immune complexes, formed either in the 
circulation (Wilson, 1981) or in situ (causer and Salant, 1980), are 
central to the immunopathogenic mechanisms responsible for glomerular 
disease. "Cellular immunological mechanisms" it has been recently 
noted (Hoedemaker , 1983) , "do not · play an imp)rtant role in the 
pathogenesis of glomerular lesions". It is acknowledged however that 
in M:NS, cell mediated irranunity might contribute to increased 
permeability of the glomerular filter. A few studies have implicated 
T cells in the development of M:NS (Shalhoub, 1979; Mallick, 1977; 
Lin, 1985) although circulating immune complexes have also been 
detected in this syndrome (Levinsky et al., 1978). The main findings 
in this report suggest the strong probability that immunoregulatory 
cells are affected, not only in minimal change but also in other 
histological types of nephrosis. 
1) Numerical Assays
a) Lymphocyte subpopulations
A redoced T4/T8 ratio was present in two of the histological groups 
studied viz. �S and Membranous NS. This might therefore be a 
feature of the nephrotic syndrome itself. This reduction was 
primarily due to an increase in the T8� subset though it was 
occasionally caused by a diminution in the percentage of T4+ cells. 
Another frequent but unexpected finding was a decrease in the nt.nnber 
of B cells. The majority of patients studied were in relapse during 
which phase these abnormalities were noted. What was equally 
interesting was that the lower T4/T8 ratio and B cells were evident 
during the clinically quiescent stage of r-1:NS. The clinical 
associations of the abnormalities in immunoregulatory cells could be
best explored in M:NS as this was the only group in which there were 
sufficient nt.nnbers of children in remission and in relapse. A similar 
degree and type of irranunological derangement was also documented in 
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membranous nephrotic syndrome; changes were rrore restricted in the 
Proliferative and Miscellaneous groups. These results probably 
indicate that dissimilar immunopathological processes underpin the 
different types of glomerular injury. It is im[X)rtant to note that 
certain intragroup difference (e.g. T8 cell numbers between remission 
and relapse in M:NS) were not detected when comparisons were drawn 
between normal controls and patients in relapse or in remission. This 
implies that such differences are subtle and the values occur at the 
extremes of the normal range during the active and inactive phases of 
the disease. 
The detection of an increase in T8 cells leading to a decreased T4/T8 
ratio in M:NS during relapse is in accordance with the findings of 
other workers (Feehally et al., 1984; Lin, 1985). On the other hand 
Gupta and Yuceoglu (1985) did not find any difference between numbers 
T '6 and Tr- cells in M:NS patients in remission or relapse compared to 
controls. Their results however cannot be strictly compared to ours as 
the tests for the identification of T cell surface antigens differ; 
the use of monoclonal antioodies as in the current study gives rrore 
reliable results. The diminution in the T4/T8 ratio and in the 
numbers of B cells recorded during remission in M:NS differs from the 
findings of similar studies (Feehally et al., 1984; Lin, 1985). 
Feehally et al. investigated patients whilst they were on 
cyclophosphamide therapy, our patients were not on this treatment. 
This may in part account for these dissimilarities. The unmasking of 
immunological abnormalities during remission raises the question of 
whether this is a period of complete quiescence due to cessation of 
processes harmful to the kidney. The evidence suggests that remission 
is a state of reduced but not absent activity. Children with minimal 
change in remission continue to have plasma inhibitory factors which 
inhibit lymphocyte transformation (Fodor et al., 1982; Chapman et al., 
1982), remain prone to severe infections resulting sometimes in death 
(Adhikari, 1981) and up to 46% have persistent biochemical 
abnormalities (Zilleruelo et al., 1984). Our findings suggest further 
that the immunological flaws detected in remission are not long 
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lasting: children who had been in remission for rrore than 5 years 
were _virtually normal with significant diminution in T8 cells compared 
to those who had been in remission for less than 5 years. However, 
the B cell lymphopenia persisted when children in remission (> 5 
years} were compared to controls. We do not know whether this 
abnormality is reversed later or is a permanent and fundamental defect 
in nephrosis. 
The redu:::tion in B cell numbers which was present in rrost patients may 
be caused by a number of factors. It may be an artifact of the test 
system in which the detection of surface irnrnunoglobulins is 
compromised by interfering compounds such as the lipids present in 
nephrotic sera or the large variety of soluble factors released by 
suppressor cells. The B lymphopenia during remission may be accounted 
for by persistent biochemical abnormalities. The protracted duration 
of the B cell defect and the redu:::tion in T8 cell numbers in long term 
remission make it less likely that this phenomenon is produ:::ed by 
suppressor T cells inhibiting B cell maturation as occurs in primary 
irranunodeficiencies (Waldmann et al., 1976). The likelihood that the B 
cell defect is critical to the pathogenesis of nephrosis bears 
investigation especially in view of the fact that B cell numbers were 
low even after 5 years remission. The above observation on redu:::ed 
numbers of B cells is complemented by previously reported .....ork which 
showed depressed in vivo (cathcart, 1981) and in vitro (Heslan and 
I.outie, 1982) function of these lymphocytes. The normal PWM 
transformation in this study suggests that the proliferative response 
of immune cells which precedes irnrnunoglobulin release is normal; this 
proliferation may be due to B and/or T cells. 
The increase in T8 cells might be due to nore suppressor lymphocytes. 
This could be a compensatory mechanism to dampen excessive activity by 
a set of cells (T cells, B cells or macrophages) stimulated by antigen 
to produ:::e glomerular damaging substances. The analogous but not 
identical situation is the irnrnonosuppression of tissue damaging 
processes observed in chronic infections (Stobo et al., 1976). On the 
other hand the T8 cells could be cytotoxic cells releasing lyrnphokines 
which increase glomerular permeability. 
VPF. In the experimental situation 
sensitised lymphocytes can migrate to 
directly in cytotoxic reactions (Nielson 
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One such 1 ymphok ine may be 
of nephritic guinea pigs, 
the kidney and participate 
and Phillips, 1979). Lastly 
the T8 lymphocytosis may be a mere epiphenomenon, a distant response 
to some primary event such as the formation of immune complexes. 
It is evident from the results that disturbances of cell mediated 
irranunity are not restricted to M:NS but. are also significant in 
membranous NS; the changes are more limited in the other 
nephropathies. Accordingly the argt.nnent that cellular immunological 
responses may be important in M:NS alone and not in other histological 
groups needs to be reconsidered. This has been previously suggested 
(Taube et al., 1984). Membranous nephrotic syndrome among black South 
African children is rrost often due to infection of a genetically 
susceptible individual by the hepatitis B virus (HBV) (Adhikari 
et al., 1985). Elimination of the virus cures the disease (Yamashita 
et al., 1983). As immunological parameters in the HBs antigen 
carriers without nephropathy were similar to those with nephropathy 
(apart from B cells) it follows that the presence of nephrotic 
syndrome does not affect the immunological deviation from normal of 
HbsAg infected individuals. To detect whether HBsAg has a particular 
effect in n-embranous nephropathy, a comparison between the HBsAg 
positive and HBsAg negative n-embranous nephropathy would have to be 
made. This was not possible as all patients except one were HBsAg 
carriers. In the parallel situation of HBV chronic active hepatitis, 
it has been suggested that an increase in T8 cells is at the centre of 
immunologically damaging mechanisms (Eddleston and Williams, 1974). 
It is worth noting that the rrost marked changes in immunoregulatory 
cells were found in the two disorders (M:NS and HBV membranous 
nephrotic syndrome) which are homogeneous among the populations 
studied in terms of histology, response to therapy, long term outcome 
and probably in triggering mechanisms (Wiggelinkhuizen and 
Sinclair-Smith, 1987). Proliferative and miscellaneous nephropathies 
represent a heterogeneous group of disorders united rrostly by a comron. 
clinical presentation; this diversity probably obscures any uniform 
changes in irnmunoregulatory cells, assuming that such changes do 
occur. 
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When all nephrotic syndrome patients (regardless of remission or 
relapse) were compared to controls these differences remained. This 
overall impression however, obscures the differences between r-cNS and 
the other three groups and between those in remission and those in 
partial remission or relaps�. The comparison is valid in that it 
conveys the totality of immune abnormalities detected in nephrotic 
syndrome in this study. The findings would be influenced .by the fact 
that the majority of patients (46 out of 68) were in relapse. A 
recent report by Lin and Hsu (1986 ) would confirm our findings. The 
two patients they studied had an increase of OKT8+ cells and NK cells 
in relapse and a decrease of these cells in remission. 
2) Functional assays
a) T suppressor cells
T suppressor cell function has been shown to be decreased in all
types of nephrotic syndrome (Taube et al., 1984) but this is not a
consistent finding. Normal ConA-indoced suppressor cell function
has been reported by Feehally et al. (1984) in children with r-cNS
in long term remission; Taube et al. (1981b) in children with MCNS
not treated with cyclophosphamide and Gupta and Yuceoglu (1985) in
three out of nine patients with r-cNS. However Wu and M:x)rthy
(1982) and Matsumoto et al. (1984b) have found increased
ConA-indoced suppressor cell activity in patients with r-cNS.
These discrepancies could be due to the different methods employed
in these studies. ConA indocible T suppressor cell function in
this study, was found to be lower, only when all histological
groups were taken together and patients included regardless ·of
remission or relapse as compared to controls. This difference
fell away when individual histological groups were compared to
their respective controls. This discrepancy between this and
other studies could also be due to the different methods employed.
It would also appear that depressed suppressor cell function
occurs in nephrosis but requires a sizeable number of
patients/control comparisons for the abnormality to be
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demonstrated. 
This latter observation was confirmed by looking at individual 
values for T suppressor cell function. At the sub-optimal level of 
ConA ie. Spg/25pl/ml of cells, 9 patients (3 with r-cNS, 3 with
extra membranous nephropathy, 1 with proliferative and 2 with 
miscellaneous nephrotic syndrome) showed enhancement whereas only 
4 of these same 9 patients( 1 with r-cNS, 1 with extra membranous 
and 2 with miscellaneous nephrotic syndrome) showed enhancement 
with the optimal level of ConA viz. 3qig/25pl/ml of cells. 
b) MNC PWM stimulation
In vitro prodoction of IgG PWM stimulation of mononuclear cells
has been found to be decreased in patients with nephrotic syndrome
in relapse compared to controls (Heslan et al., 1982) • MNC PWM
stimulation in all our patients was not adversely affected;
neither histological grouping nor clinical condition had an
effect. Al though B cell numbers were found to be decreased
(mentioned under Numerical assays), particularly in children with
r-cNS in remission and membranous nephrotic syndrome, this did not
correlate with the functional assay we employed. It could be
argued, that MN: PWM stimulation is a coq,lex test measuring the
functions of antigen presenting cells, T helper and B cells. We
did not measure the final prodoct ie. irranunoglobulins and
therefore these results merely suggest that the proliferative
response of these cells may be normal.
3) The Effect of previous Treatment
There is conflicting evidence about the effect of steroid 
treatment in nephrotic syndrome. Taube et al. (1981b) found that 
cyclophosphamide treatment had a long term impairment of T 
suppression cell function in r-cNS (up to 12 years mean 6,5 years) 
whereas Feehally et al., 1984 reported a transient defect of T4+
cells up to 6 rronths after cyclophosphamide treatment. 
OJr attempts to elucidate whether prednisone on its own or in 
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combination with other drugs had any effect on the parameters 
studied failed as only 1 patient had previously been treated with 
prednisone + cyclophosphamide + chlorambucil. 
4) The Effect of Infection and Relapse on the Immune Response
The critical event which precipitates relapse in nephrosis is 
usually not discernible though mild infections are often held to 
be responsible. 0..lr results show that the rates of infection and 
of relapse correlate with white cells and T cells. This would 
support the corranonly held view that infections tip the scales 
toward increased glomerular permeability and overt disease. 
The findings in t-CNS that certain lymphocyte subpopulations, 
particularly T cells comprising mainly of OKT8+ cells confirms 
further, lx>th in this study and as in others, that T cells have a 
central role in the pathogenesis of t-CNS. The similarity in 
irmnunol<?9ical parameters which were related to relapse as well as 
in infection was not surprising, as in the clinical situation, 
almost without fail, when the patient gets an infection he/she 
relapses. 
In M:NS, in remission it was also observed that there was an 
increase in the number of infections/per year over those t-CNS 
children in relapse. However, although TS+ cells have been shown 
to be important in t-CNS, the additional effect of cytotoxic cells 
cannot be ruled out. 
Although in membranous nephrq,athy abnormalities of the immune 
response were detected, these did not relate to infection. In 
proliferative and miscellaneous types of nephrotic syndrome, it 
seems that infection is not related to any immunodeficiency. 
5) Correlation of tests
The reasons for the lack of correlation between the numerical and 
functional assays of suppression as detected even in this study 
has been previously discussed. (See Chapter on Measles) 
6) The Effect of HBs antigenaemia
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In the African child, in Southern Africa it has been suggested 
that the interaction of the presence of HBs antigen together with 
a genetic predisposition is central to the pathogenesis of 
membranous nephropathy (Adhikari et al., 1985). This study 
confirmed this observation in that 13 out of 14 children who were 
all African in the membranous histological group were HBs antigen 
positive while all the Indian children in all 4 histological 
groups were HBs antigen negative. 
An increase in TB+ has been implicated as playing a pathogenetic 
role in HBs antigen positive chronic active hepatitis (Eddleston 
and Williams, 1974). An increase in T suppressor/cytotoxic cells 
were fo_und in membranous nephropathy. However, as mentioned 
previously, the immunological abnormalities noted in membranous 
nephropathy are due to renal disease. 
CONCLUSION 
The results obtained in this study suggest that derangements of 
irnrm.moregulatory cells may underpin abnormalities related to 
susceptibility to infection and the irnmunopathogenesis noted in the 
nephrotic syndrome of childhood. 
The changes of immunoregulatory cells reported here need to be 
explored further. If these findings are conf1rmed the therapeutic 
implications are that it may be possible to find alternatives to the 
widely used drugs, such as steroids and cyclophosphamide, which have 
many serious side effects. A sustained effort must be made to 
minimise relapses by reducing the rate of infections in nephrotic 
children. 
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B CHRONIC RENAL FAILURE ( CRF) 
AIM 
This study was undertaken to examine the immunoregulatory changes in 
patients who proceed to chron�c renal failure (CRF). All patients bar 
two adolescents, were adults. I will not elaborate too much on 
historical and other details (as previously) but mention them briefly 
and concentrate mainly on the immunological findings. 
SUMMARY 
CHRONIC RENAL FAILURE (CRF: SUPPRESSOR CELLS ASSAYED BY NUMERICAL AND 
FUNCTIONAL TESTS IN CHRONIC RENAL FAILURE). 
Suppressor cells were assayed by mnnerical and functional tests in 
adults on chronic haemodialysis. Peripheral blood rononuclears (PMB) 
were classified as total T cells by E-rosettes and by the ronoclonal 
antibody OKT3, as T cell subsets by OKT4 (inducer/helper T cells) and 
OKT8 (cytotoxic/suppressor T cells) and as B cells by the presence of 
surface imrnunoglobulin. The suppressive effect of PBM pretreated with 
either concanavalin A (ConA), sodium periodate, or serum rich in 
irnrnune complexes, on normal homologous phytohaernagglutinin (PHA) 
lymphocyte transformation, was determined. Usual tests of T cell 
function were not done. T lyrnphopenia was due to significant 
diminution (�O,CC02) in numbers of OKT4+ cells in patients (516 ±. 44
cells/rnrn3 mean ±. SEM) as compared to controls (906 ±. 96 cells/mm3 ).
The number of OKT8+ cells in patients was not different from normal
although their percentage (45 ±. 4%) was slightly higher than controls 
(36 ±. 5%) (�0,10). Suppressor activity using only a suboptimal dose 
of ConA (5pg/ml), was significantly lower (p<0,002) in uraemic 
patients (36 ±. 12%) than in controls (67 ±. 7%). An irnf()rtant finding 
was that no significant correlations were detected between the 
numerical and functional assays of suppression used or between any of 
these immunological tests and biochemical parameters studied. The 
implications of these results for irnrnunoparesis in uraemia are 
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discussed with particular reference to the discordance between marker 
and functional assays of suppressor cells. 
INTRODUCTION 
Uremia is known to be immunosuppressive (Lawrence, 1965; Dobbelstein, 
1976; Mannick et al., 1960; Hanicki et al., 1979; Sengar et al., 1975; 
Harris and Sengar, 1975; Kunori et al., 1980; Darnmin et al.� 1957) and 
the clinical relevance of this is seen in the high incidence of 
infections and neoplasia (Lindner et al., 1981) recorded in these 
patients. The mechanisms responsible for this relative anergy are 
unknown and have been ascribed to many factors including unspecified 
uremic toxins and malnutrition. 
Impaired cell mediated immunity in uremic rats accompanied by 
increased activity of suppressor cells (Raskova and r-brr ison, 1976) 
and of T-cell depletion associated with retention or even augmentation 
of suppressor cell activity in renal failure patients on hemodialysis 
(Guillou et al., 1980) suggest an important role for immunoregulatory 
cells in this disease. 
Discordant results between different functional assays of suppression 
in autoimmure disease (Coovadia et al., 1981) indicate that there was, 
at the time the study was undertaken (1981-1982), no single 
satisfactory test to measure this component of the immune response. 
These facts prompted us to compare several functional suppressor cell 
assays and attempt to correlate these with numerical estimates of 
T-cell subsets using specific murine rronoclonal antibody in a further
attempt to elu::idate the immunodeficiency in uremia. Conventional
tests of T-cell function such as delayed hypersensitivity,
cytotoxic i ty, help and suppression of immunoglobulin synthesis were
not performed. As the uremic state is characterized by wide
flu::tuations in biochemical indices, and as some of these have been
shown to have adverse effects on the immune response (Harwick et al.,
1978) , we also assessed the influence of serum levels of selected
metal and nutrients on the tests of immunity studied in these
patients.
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MATERIALS AND METHODS 
PATIENTS 
Patient Details (Table 57, Figure 93) 
Nineteen patients undergoing regular hernodialysis (4 to 5, 5 hours, 
three times a week), at the Addington Hospital, Durban, were studied. 
They .ranged in age from 15 to 63 years (mean, 35 years). There were 
ten White and nine Indian patients: 14 were male. Chronic renal 
failure was ascribed to chronic glomerulonephritis in 6 patients and 
analgesic nephropathy in four. Chronic pyelonephritis, malignant 
hypertension and Alpxt syndrome accounted two patients, while the 
remaining three patients had crescentic nephritis, systemic lupus 
erythematosus and polycystic kidney disease. The patient with 
crescentic nephritis was on daily oral doses of 20mg prenisilone and 
150mg cyclophosphamide. One patient with glomerulonephritis had been 
successfully treated surgically for a hypernephroma, diagnosed at the 
time of presentation with CRF. 
All blcx:xi samples were taken prior to hemodialysis and immediately 
before systemic heparinization. As patients were lymphopenic, all the 
tests discussed below could not be done on every individual. The 
exact number studied is given in the tables. 




(i) T and B subpopulations
(This was undertaken as described under Methods)
(ii) T cell subsets using monoclonal antibodies.
(This was undertaken as described under Methods)




{This was undertaken as described under Methoos) 
II Biochemical investigations 
The following routine biochemical and haematological tests_ were done 
using standard techniques at the same time as the immunological assays 
on the peripheral blood of the uremic patients: urea and 
electrolytes; creatinine, calcium, phosphate, alkaline phosphatase, 
magnesium, uric acid, folic acid, serum iron and total iron binding 
capacity triglycerides, cholesterol, albumin, globulin, haemoglobin 
and white cell count. In addition, plasma zinc levels were estimated 
by atomic absorption {Hackley et al., 1968). 
III Nutritional status 
This was assessed by measurements of weight and height and by 
estimates of mid arm muscle circumference calculated from the mid-arm 
circumference and skin fold thickness, using a Harpenden skin-fold 
caliper {Jelliffe, 1966). 
Statistical Analysis 
Results were analysed using the non-parametric Mann-Whitney u test. 
The computed u statistic was tested at a 5% level of significance. 
Correlation analysis was performed by testing the linear correlation 
coefficient at a 5% level of significance. 
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RESULTS 
Nutritional indices. The hemodialysis patients were found to have an 
adequate level of nutrition • 
. Biochemical Investigations {Table 58) 
None had a serum albumin level below· 30 g/liter; only two had serum 
folate levels below 5 rrg/ml and percentage transferrin saturation less 
than 15%, and three out of 14 patients who had estimations of mid-arm 
muscle circumference had results below 80% of the standard {Jelliffe, 
1966). 
The results of these assays are set out in Table 
The patients with uremia had a significant 
of total PBM as well as a T cell lymphopenia as 
Numerical assays. 
59, Figures 94-97) 
absolute lymphopenia 
measured both by the E-rosette technique and the m:moclonal antibody 
OKT3+. There was significant positive correlation between the total T 
cell population measured by these two techniques in both the normal 
controls {sample correlation coefficient R=0,745 p=0,001) and in the 
patients with chronic renal failure {R=0,917 p=0,01). 
The OKT3+ population was consistently smaller than the E-rosette 
population in the controls. OKT3+ and E-rosette cells formed 49 and 
7 4 % , respectively, of the total absolute rrononuc !ear count. The 
OKT3+ cells amounted to 67,0% of the E-rosette subset in the controls. 
Similarly, in patients, OKT3+ cells accounted for 44% and E-rosette 
cells for 74% of the total rrononuclear count. 
Paralleling the T cell lymphopenia, there was an absolute B cell 
{Sig+) lymphopenia in patients, while there was no difference in the 
Null cell counts between the patients and controls. The absolute 
number of OKT4+ cells in the patients was significantly lower than the 
controls, but when these results were expressed as a percentage OKT3+ 
cells, no difference was found. The absolute number of OKT8+ cells 
was not significantly different from normals. However, the mean 
percentage of OKT8+ cells was slightly higher in the patients than in 
controls {p=0,001). The results expressed as the ratio of OKT4 cells 
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Table 58 Biochemical investigations in uremic patients* 
Subject group Patients Normal range 
Urea 30,03 + 
-
1,78 i,50 to 6,50 
Creatinine, umole/li ter 1193,89 + 62,20 53,(X) to 97,(X) 
Zinc, pg/ml 1,16 .:t, 0,05 o, 70 to 1,00 
Magnesium 1,21 + 0,04 0,74 to 0,99 
calcium 2,17 + 0,05 2,25 to 2,75 
Phosphate 2, 26 .:t, 0,14 0,81 to 1,45 
Alkaline phosphatase /Uliter 153,50 + 27,30 30,(X) to 85,00 
Uric acid 0,47 + 0,02 0,25 to 0,42 
Folic acid, ng/ml 14,10 + 1,30 5,(X) to 20,00 
% Saturation transferrin 38,40 .:t, 5,90 > 15,00
Triglyceride 2,10 + 0,26 0,34 to 1,69 
Cholesterol 4,80 + 0,52 3,89 to 6,48 
Albumin g/liter 40,00 + 0,85 38,(X) to 48,00 
Globulin g/liter 27,20 .:t, 1,28 20,00 to 32,00 
Hemoglobin, g/dl 7,30 + 0,24 12,00 to 18,00 
*All results are expressed as the mean + SEM and in millimoles per







to OKT8 cells showed significant deviations from normal (p=0,01). 
Functional assays of suppression. The results are shown in Table 60, 
Figure 98) 
The only significant finding was a lower level of suppressor activity 
in uremic patients as compared to control subjects when using the 
suboptimal dose of ConA (5 pg/ml). 
Correlations. No significant correlation was found between any of the 
numerical assays and the tests of suppressor cell function in both the 
normal control and uremic groups. Similarly, no significant 
correlations were detected between any of the biochemical parameters 
estimated and the immunological tests performed. 
No correlations were observed between all numerical assays employed 
and the preincubation test with either PHA or ConA in the control 
group. 
Table 60. Assays of suppressor cell function in patients on chronic 
hemodialysis and normal controlsa




Patient no. 5 pg/ml 30 1-1g/ml per iodate 
1 -39 ND ND 
2 -6 51 -24
3 97 99 99
4 -3 ND -3,6
5 15 84 97
6 ND ND ND 
7 58 86 68
8 ND ND ND 
9 ND ND ND 
10 23 92 24 
11 79 ND ND 
12 43 ND 87 
13 99 ND ND 
14 1 ND 2 
15 50 94 24 
16 -21 -23 -20
17 86 ND ND
18 ND ND ND 
19 ND ND ND 
All patients 36+12b 7o+l6 33+16 
Controls 67+ 7 81+ 7 -54+32
Probability <0,002 >0,10 <0,10
value >0,05
a % Suppression = (1 - �DPM mitogen-stirnulated cells)


























l::._DPM = DPM of mitogen stimulated cells - DPM of cells without mitogen. 




The redu::tion in the total circulating lymphocytes, and T- and B-cell 
populations confirms previous reports in uremia (Sengar et al., 1975; 
Harris and Sengar, 1975). In keeping with the general cell depletion 
is the new finding of a significant redu::tion of the T-helper/indu::er 
subset. The unusual finding · of a normal number of 
T-suppressor/cytotoxic cells iri the presence of marked depletion of
total lymphocytes might suggest that the relative predominance of 
these cells could upset the regulatory balance in the irranune 
homeostatic mechanisms and account for the anergy in uremia. However, 
the certainty of this interpretation tends to be diminished by the 
findings of a low ConA indu::ed suppressor activity in these patients. 
This significantly low level of Con A-indu::ed suppression is similar 
to that described in auto-irranune diseases (Coovadia et al., 1981) but 
contrasts with previous reports of augmented suppressor function in 
uremia using other experimental techniques (Rask ova and M::>rr ison, 
1976) ; Guillou et al., 1980) which, however, are less reprodu:: ible 
(Coovadia et al., 1981). 
The consistently smaller 0KT3 population as compared to E-rosettes was 
not totally unexpected, as the technique of floorescence microscopy 
used here, is known to give lower results than that obtained using 
flow cytornetric analysis. In addition, it is possible that all 
E-rosette forming cells are not T-cells and all mature T-cells do not
express the specific antigen detected by the 0KT3 antil:x)dy. The sum 
of the OKT4+ and OKT8+ cells was fra'.l uently greater than the total 
number of OKT3+ cells. This may suggest that the 0KT3 antil:x)dy is 
underestimating the total T-cell population or that there is a 
population of cells that has both these antigens. A group of 
double-marker cells, in fact, has been demonstrated in myasthenia 
gravis where they were interpreted as being immature cells (Berrih 
et al., 1981) • 
The reasons for the lack of correlation between the mnnerical and 
functional assays among both controls and patients as found in this 
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study have been dealt with elsewhere. (See Chapter on Measles) The 
dissociation between marker and functional assays which we have shown 
here · and elsewhere (Coovadia et al., 1981) has also emerged from 
another report (Bach et al., 1981) using the same rronoclonal 
·"' antibodies used in this study. In patients with leprosy, a decrease
in both in vivo and in vitro.tests of function attributed to T-helper
cells, was not accompanied by the expected redoction of OKT4 cells. 
The ·generation of suppressor activity by sodium periodate and 
circulating immune complexes prodoced extremely variable results with 
fre:iuent and unpredictable stimulation, rather than suppression of the 
PHA response. The suboptimal dose of 5 pg/ml ConA in this study was 
rrost effective at demonstrating the difference between the control and 
patient groups. 
LOss of suppressor function has been shown in patients with systemic 
lupus erythematosus (Bresnihan and Jasin, 1977) using the 
preincubatiqn method. Our attempts, using the same method, to detect 
suppressor function in patients with CRF were hampered because of the 
insufficient number of rrononuclear cells obtained. 
As the majority of patients tested by us were reasonably nourished, 
malnutrition cannot be implicated as a cause of the anergy in uremia. 
In evaluating the above findings greater reliance has to be placed on 
the ntnnerical assays using rronoclonal antibodies which give simple and 
reliable results rather than the functional assays which are subject 
to technical variations and whose physiological significance is 
unclear. 
Therefore, the evidence given above on the numerical imbalance between 
suppressor and helper T-cells suggests that altered suppressor cell 
activity may be a cause of the immunoparesis in uremia. 
NEUROMUSCULAR DISEASES 
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NEURCMUSCULAR DISORDERS: EVALUATION OF IMMUNOREGUI.ATORY CELLS IN DMD 
AND SMA AMONG AFRICAN AND INDIAN PATIENTS 
AIM 
This study was undertaken to observe whether there is any disturbance 
in irnmunoregulatory cells in Il.fil and SMA. 
SUMW>..RY 
Suppressor cells were assayed by nurner ical and functional tests in 
Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA) 
airong African and Indian children in order to contribute to an 
understanding of the pathogenesis of these neurological disorders. 
Peripheral blood rrononuclears (PBM) were classified as total T cells 
and T cell subsets by the OKT series of rronoclonal antibodies and as B 
cells by the presence of surface imrnunoglobulin. The suppressive 
effects of PBM pretreated with concanavalin A (Con A) on normal 
horrologous phytohaernagglutinin (PHA) transformation of m:::monuc:lear 
cells was determined. PBM stimulation by PHA was also assessed. 
Patients with DMD had a significant increase (p = 0,035 3) in the 
number of T suppressor/cytotoxic cells (1218 _:t 142 cells/rnm3 mean + 
SEM) as compared to controls (815 _:t 95 cells/rnrn3) and a significant
redoction (p = 0,0282) in OKT4+ cells expressed as a percentage of
OKT3+ , 50% + 3 compared to 61 % + 3.
No differences were detected in any of the numerical assays employed 
in SM A as compared to controls, or within SMA patients according to 
severity of disease. 
Suppressor function and PHA transformation were normal in both groups 
of patients. 
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No significant correlations were detected between numerical and 
functional assays of suppression. 
The implication of the results obtained for the role of 




A vast number of clinical disorders, both acute and chronic, 
hereditary and a�uired, affect the lower rrotor neurone (Dyck et al., 
1975). The lesion may be in the anterior horn cell or rrore distally 
along the course of the peripheral nerve. Some disorders affect only 
rrotor nerves, others the sensory as well. In some the. peripheral 
neuropathy occurs in isolati�n, in others it is associated with 
invoivement of the spinal tracts or other parts of the central nervous 
system (CNS). Spinal muscular atrophy is a chronic disorder, mainly 
hereditary, which predominantly affect the rrotor nerves and therefore 
likely to overlap with other disorders of muscle. 
The muscular dystrophies are a group of genetically determined 
disorders with progressive degeneration of skeletal muscle and no 
associated structural abnormality in the central nervous system or 
peripheral nerves. 
It has been observed in other disorders where muscle weakness is a 
feature (eg. polymyositis, dermatomyositis, multiple _sclerosis, that T 
cells and/or their prodocts may be responsible for the inflammatory 
infiltrate and necrosis of muscle. Therefore it was of interest to 
study the above two mentioned disorders in order to show whether the 
direct or indirect degeneration of muscle leads to a change in the 
number (s) and function of cells involved in the irronune regulatory 
network or vice versa. 
A)  Spinal Muscular Atrophy (SMA) 
Genetics 
M::>st forms of SMA have a hereditary basis. In the severe form as well 
as the milder forms, the pattern of inheritance has usually been 
autosomal recessive. Apart from the usual autosomal recessive node of 
inheritance there have been a number of reports of SMA with dominant 
inheritance (Armstrong et al., 1966; Zellweger et al., 1972). 
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Some · cases of SMA may be non-genetic and may be environmentally 
prodoced (Pearn et al., 1978) but searches for specific causative 
agents (Pearn, 1978; Pearn, 1979) such as trace elements, 
abnormalities and associated diseases have so far proved fruitless. 
In the African population, unlike the European and Asian communities 
where it is inherited as an autosomal recessive disorder, cases of SMA 
are .mainly sporadic in nature (MJosa, A. and Dawcod, 1986) and 
therefore preslll11ably acx:iuired. 
There appears to be no prer0:1uisite for inheritance as far as social 
class, maternal or paternal age, or area of birth is concerned. 
It was not known whether the various types of progressive SMA with 
autosomal recessive inheritance and onset in infancy or childhood was 
one disease entity always due to the same gene or whether separate 
genes caused different types. Fearn (1980) by the use of genetic 
techniques on familial studies showed that there are several distinct 
SMA genes each with their different clinical syndromes. It is now 
possible to define individuals (and families) affected by these 
separate genes which is of extreme importance from a genetic 
counselling point of view in conveying the appropriate risk figures to 
the subject seeking genetic advice. 
Pathogenesis 
Apart from the genetic basis, the underlying cause and pathogenesis of 
the disease remain obscure. Acute onset of symptoms of SMA have been 
found after vaccination to: smallpox (Dubowi tz, 1964) ; 
diptheria-pertussis (Gardner-Medwin et al., 1967) or miscellaneous 
infectious illnesses (M..lnsat et al., 1969). In other instances it was 
found that there was an increase in pre-existing weakness following or 
acute infection (M..lnsat et al., 1969) or measles (Gardner-Medwin 
et al., 1967). It is, however, difficult to determine whether this is 
of any significance particularly as SMA is in rrost instances a 
genetically determined disorder. 
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Beckman et al. (1970) suggested that it could be due to an in utero 
infection by poliomyelitis virus, perhaps associated with the 
widespread use of oral poliomyelitis vaccine. Hogenhuis et al. (1967) 
were unable to show any abnormality in RNA metaoolism by 
autoradiographic assessment ·of uptake of tritiated uridine in the 
anterior horn cells in infantile Sr,1A. These experiments suggested 
that an RNA virus, such as poliomyelitis, was unlikely. However, this 
picture may not be true in African children with SMA where cases are 
found to be sporadic and the use of oral poliomyelitis vaccine is not 
yet widespread, it could indeed be due to an ongoing viral process 
either due to poliomyelitis or coxsackie virus (M:)Osa, A., personal 
communication). 
Low Vitamin E in the plasma has also been found in seven out of eight 
children with Werdnig-Hoffman disease (Shapira et al., 1981) • High 
doses of vitamin E were given orally resulting in an increase of 
plasma levels but no clinical improvement was seen. N:)rmal levels of 
Vitamin E in SMA have also been reported (SOkol and Iannaccone 1983). 
The role of Vitamin E deficiency in the pathogenesis of neurological 
deficits is therefore uncertain. 
The Immune State of Patients with SMA 
There is some evidence that the immune response is affected in SMA. 
Several authors (Hausmanowa-Petrusewisz and Fidzianska-Dolof 1975; 
Ryniewicz and Pawinska 1978) have observed that 50% of children with 
Werdnig-Hoffman disease have tonsils and adenoids which were atrophic 
and in 18% both these lymphatic tissues were lacking. This is in 
contrast to castrovieja's findings (1984) who did not find this in his 
patients. 
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Specific Irranune Res}?Onse 
Number of Cells 
There have been no studies of irnmunoregulatory cell numbers in SMA to 
date. 
Function of cells 
Lymphocyte transformation to PHA has been shown to be significantly 
decreased in children with Werdnig-Hoffman disease as compared to 
normal children (Ryniewicz and Pawinska, 1978) • The same authors 
found that the skin test to PPD was negative in 97% of these children 
as comp:tred to J?OSitive in 85% of controls. They suggested that this 
decrease in CMI was due to a change in lymphocyte reactivity which may 
be related to an ectodermal defect involving both the spinal cord and 
the thymus,. as patients' serum did not affect blast transformation to 
PHA of lymphocytes from healthy subjects. It has also been observed 
that similar low values of lymphocyte transformation were present in 
children with the Kughelberg-Welander type of SMA and not only in the 
nost severely affected (Ryniewicz and Pawinska, 1978). 
Non Specific Irranune resJ?Onse 
Serum IgA and IgM concentrations have been shown to be decreased in 
patients with SMA as compared to controls (Migaj et al., 1986). 
B) Duchenne Muscular Dystrophy (DMD)
Genetics 
The classical form of Duchenne dystrophy is inherited through an 
X-linked gene in two thirds of the cases and the remaining one third
is secondary to a new mutation. Thus it is only confined to males. It 
is characterized by progressive muscle wasting and weakness which 
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become clinically evident around the age of three to five years and 
lead to an inability to walk by the age of 12 and death in the late 
teens or early twenties (Walton and Nattrass, 1954). 
The locus for CTvID is not within measurable distance of either the Xg 
locus (Blyth et al., 1965) or the ·colour vision locus (Emery, 1966; 
Greig, 1977). Cytological eyidence suggests that it is in. the middle 
of the short arm of the X chromosome (Xp 21) (COnneally, 1985). 
There is also a high mutation rate. Different authors have estimated 
this mutation rate to be 95 per million genes per generation 65 per 
million and 43 per million (Dubowitz, 1978). This is one of the 
highest mutation rates for any human disease. The corresponding 
mutation rate for haemophilia is about 20 to 30 per million. 
The incidence of the disease is not known for certain and estimates in 
male infants vary from 1/1700 in Germany to 1/6000 in France (Moosa, 
1982). 
It is therefore extremely important to diagnose this disorder early in 
order to detect carriers and offer genetic counselling. One of the 
investigations apart from the clinical assessment that one can do is 
to measure serum Creatinine Kinase (CK) levels ( this enzyme is a 
sensitive index of myofiber damage) either of newborn male infants 
(Zellweger and Antonik, 1975) or of male infants who are not walking 
by the age of 18 months (Gardner-Medwin, 1978) in order to determine 
whether the child has this disorder or not. A gross elevation of CK 
level strongly indicates this disease. This should then be followed 
by the investigation of all female relatives of the patient ( s) for 
carrier status and thereafter genetic advice should be given by 
experienced persons to the parents concerned. Hoi;..ever, Gardner-Medwin 
(1979) has pointed out that there is no guarantee that parents will 
heed the genetic advice given. Perhaps for the simple reason that 
they would opt to take the l-in-2 risk of having a normal son. 
Dubowitz has suggested that if the woman is still keen to have a child 
in spite of the high risk, one may be able to offer selective abortion 
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of a male foetus by sexing the fetus at about 14 weeks' gestation. 
There_ is at present no reliable way of telling whether a male foetus 
is affected by dystrophy or not. Analysis of foetal blood samples for 
CK levels has not proved as helpful as was originally thought. DNA 
probes, however, hold out real possibility of antenatal diagnosis. 
Pathogenesis 
DMD is a single disease entity. The clinical features are uniform, 
the histopathologic findings are characteristic, the serum enzymes are 
always elevated early in the course and the outcome, unfortunately is 
always predictable. However, the pathogenesis of muscular dystrophy 
is not clearly understood. Dystrophic muscle is composed of living, 
dying, dead and regenerating muscle fibres in varying proportions 
according to the stage of the disease. In healthy muscle fibre, 
necrosis is usually followed by regeneration of the affected fibres. 
Although regeneration also occurs in diseased muscle, it is thought 
that the regenerated fibres, may in turn, themselves become necrotic 
if the causative factor continues to act, thereby resulting in a 
recurring cycle of necrosis and regeneration. 
Muscle fibre necrosis is seen from an early stage, even before the 
disease becomes clinically manifest, with hyaline fibres present in 
considerable numbers prior to invasion by phagocytes. The necrosis 
may be segmental suggesting that the factor(s) responsible for 
damaging the fibre act focally, or the necrotic (and regenerating) 
fibres may be grouped suggesting that focal ischaemia may be
responsible for the muscle damage (Hathaway et al., 1970). 
The actual cellular mechanism leading to muscle fibre degeneration and 
death in DMD is also not clear cut. Studies of muscle surface 
membrane (J.l.bkri et al., 1975) have revealed gaps in the plasma 
membrane that may allow the permeability of abnormally large rrolecules 
and ions eg. ca2+. Whether this stroctural defect in the plasma
membrane is a primary event in the course of muscle fibre breakdown or 
whether this particular lesion is secondary to a biochemical lesion 
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elsewhere in the muscle fibre is unknown. Furthermore, if the cause 
of the structural defect resided in the membrane itself, it could be 
caused by an abnormal lipid component or by a defective structural 
protein in the membrane. 
Membrane abnormalities have previously been proposed in red blood 
cells in DMD viz. abnormality in the lipid profile and ."fatty acid 
patt�rns in muscle membrane ·phospholipids (Kunze et al., 1973); 
increased protein phosphorylation (Roses et a�., 1975) and that red 
blood cells were prone to form echinocytes (Matheson and Howland, 
1974). Some of these findings have not been confirmed by other 
workers, hov.ever, and the significance of such changes is not clear. 
Although many workers agree that the generalized membrane defect in 
DMD is genetic others have reported that these abnormalities may be 
indoced by factors in the patients' plasma (Siddiqui and Pennington, 
1977) • 
M abnormallty in lymphocytes concerning their "capping" phenomenon 
has also been reported in DMD (Verrill et al., 1977; Pickard et al., 
1978) but subs0:1uent attempts to confirm this have been conflicting. 
Abnormalities in collagen synthesis in cultures of Duchenne 
fibroblasts (Ionasescu et al., 1977) and of abnormal fibroblast 
adhesiveness (Jones and Witkowski, 1979) have been found. 
Studies of the repair processes of skeletal muscle have shown that 
this tissue possesses considerable pov.ers of regeneration. Murray 
(1972) postulated that rrononuclear muscle precursor cells are formed 
and that these multiply by mitosis, subs0:1uently fusing to form the 
myotubes from which new muscle fibres develop. These precursor cells 
or myoblasts are probably derived, at least in part, from satellite 
cells (Maur, 1961). The same myoblast fusion mechanism appears to be 
operative in embryogenesis (Mintz and Baker, 1967) in normal growth, 
in injured and diseased muscle and in muscle grafts. The source of 
the mononuclear muscle cell precursors is uncertain. It could be that 
an undifferentiated satellite precursor cell could persist through 
adult life (Snow, 1978) lying between plasma and basement membranes of 
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the muscle fibre or it could be that myoblasts can arise by 
segregation of differentiated myonuclei (Walker, 1972). It also 
remains possible that local connective tissue cells and, in 
particular, circulating cells may have an accessory role in myogenesis 
(Toto et al., 1967). 
The prospect of an eventual _underst�ding of the basic defect in ™D 
lies in defining the genes that are active in ne.uromuscular 
differentiation and which are X-linked. Monaco et a_!. (1985) have 
described the successful cloning of a DNA fragment that detects a 
deletion which is in or very near the DMD gene. These authors 
hybridized excess DNA from a patient with DMD with a deletion to OOA 
from normal humans. The principle of the technique was that the DNA 
which failed to hybridize was enriched with se:;iuences from the region 
of the deletion, hence identifying the chrooosomal deletion of the 
affected gene. t-Dnaco et al. described how seven of these probes from 
the region deleted in one DMD patient were used to check for deletions 
in DMD patients. Five of 57 males with DMD were found to have 
deletions, each missing at least 38 Kilobases of genomic DNA. By 
using these probes accurate prenatal diagnosis and carrier detection 
will be made available for families of affected children and rrost 
important in determining the aetiology of DMD which will hopefully 
provide insights into the basic mechanisms of this muscle disease. 
The immune state in patients with DMD 
As discussed under pathogenesis there was evidence, although 
controversial, to show that the "capping" phenomenon of the lymphocyte 
membrane structure was redu:;ed (Pickard et al., 1978) • These authors 
suggest that the altered membrane fluidity may be expressed as 
conformational changes on the surface of B lymphocytes. 
In certain other myopathies eg. polymyositis and dermatomysitis and in 
diseases of the CNS eg. multiple sclerosis both cellular and humor al 
factors of the immune system have been suggested to be important 
factors in the aetioliogy and/or pathogenesis of these disorders. 
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Specific Immune Response 
a) Number of cells
There have been no studies on cell numbers of the immune system in IMO 
to date. However, disturbances in .the number of immunor!:=gulatory T 
cell� have been reported in other disorder_s of CNS involving muscle 
weakness eg. multiple sclerosis and myasthenia gravis. In both these 
conditions a redu::tion in the circulating T-suppressor cell subset has 
been demonstrated (Santoli, et al., 1978; Skolnik, et al., 1982). 
Bresnan et al. (1981) similarly reported a loss of circulating 
T-suppressor cells during the active phase of dermatomyositis in two
children, while Iyer et al. (1983) failed to demonstrate any change in 
T cell subsets in one case of active and untreated dermatomyositis and 
in six cases of polymyositis. 
b) Function of cells
Similarly, no studies have been done on the function of the different 
cells of the immune system in DMD. It has been shown, however, that 
lymphocytes from the cerebrospinal fluid (CSF) as well as from the 
peripheral blood from patients with multiple sclerosis (MS) were able 
to respond better to PHA and to measles antigen than to other antigens 
viz. rubella, mumps, and herpes simplex (Reunanen et al., 1983) • 
These authors also found that the CSF cellular response to PHA or 
measles virus antigen (MVA) and the rate of intrathecal antibody 
synthesis to MVA showed an inverse trend, suggesting that the 
stimulated cells may at least partially represent suppressor cells. 
This excess intrathecal synthesis of certain antibody specificities in 
multiple sclerosis could be explained by the fact that the 
distribution of T cell subpopulations appear to be different in CSF 
and peripheral blood in MS (Merrill et al., 1980) • It could also 
suggest that the function of controlling T cell subsets between CNS 
and peripheral blood are different. 
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Peripheral lymphocytes of patients with active polymyositis were 
cytotoxic to human fetal muscle cultures (Currie et al., 1971; Dawkins 
et al., 1973) and produ::ed lymphokines when incubated with autologous 
muscle in medium free of irnrnunoglobulins (Haas et al., 1974). 
Non specific Immune Response 
a) Antioody and Complement
Antioodies against muscle components have been consistently 
demonstrated in polymyositis and dermatomyositis (caspary et al., 
1964; Stern et al., 1967; Currie, 1981) where deposits of IgG, IgM and 
C3 have been found in the vessel walls. However , no studies on 
hurnoral factors have been investigated in CMD. 
, 
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Materials and Methods 
PATIENTS (Tables 61, 62) 
20 children (of whom 19 were ·male) with sex-linked recessive mode-of 
inheritance of DMD were studied at. the King Edward VI II. Hospital, 
Durban. The diagnosis was confirmed clinically and histologically. 
They were between 3-17 years (median age 8 years) and 14 were Indian 
and 6 African. One female patient in this study was a manifesting 
carrier. Four of the older patients were confined to a wheelchair 
while the rest were still ambulant at the time of study. Sixteen 
children and 1 adult with clinically and histolog ically confirmed SMA 
aged between 1 rronth-37 years (median age 1 year 7 months) of whom 2 
were Indian males and 15 African (of whom 4 were males) v.ere studied 
at the same hospital. Five children had severe SMA, nine intermediate 
and three mild. 
The patients with DMD and SMA were age - sex - and race matched 
separately with normal healthy children who were part of an 
epidemiological survey of the prevalence of Hepatitis B (See Chapter 
on Normal developnent of Immune Response). Informed consent from the 
parents of patients and controls was obtained prior to blood samples 
being taken. The nutritional state of the patients was satisfactory. 
All were above the 5th centile of weight for height according to the 




Clinical data on patients with DMD 
Patient Age Sex Race 
No (years) 
1 5 M I 
2 8 F I (carrier) 
3 11 M A 
4 3 M I 
5 5l/2 M I 
6 8 M A 
7 6 M I 
8 12 M 
:J* 9 17 M both not ambulant 
10 8 M A 
11 9 M I 
12 5 M I 
13 11 M I not ambulant 
14 4 M 
:}
o 
15 6 M 
16 9 M A 
17 7 M 
:J
+ 
18 7 M 
19 10 M A 
20 13 M A not ambulant 
Abbreviations: I = Indian South African; A = African South African 
F = Female ; M - Male 
*, 0, +=Brothers of 3 separate families 
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Table 62 
Clinical data on patients with S.MA 
Patient Age Sex Race Degree of severity 
(years) 
1 9 F A Mild 
2 37 M A Mild 
3 3 F A Intermediate 
4 18 F A Mild 
5 
3112 F A Severe 
6 29112 F A In termed ia te 
7 
3112 F A Severe 
8 17112 F A Intermediate 
9 6 M I In termed ia te 
10 
9112 F A Intermediate 
11 
6/12 M I Severe 
12 l/12 F A Severe 
13 35112 F A Intermediate 
14 9112 F A Intermediate 
15 5/12 M A Severe 
16 1 M A Intermediate 
17 3 M A Intermediate 
Abbreviations: I =  Indian South African; A =  African South African 
F = Female; M = Male 
Immunological Investigations 
1. Absolute lymphocyte counts were done on the Coulter counter and
differential counts by routine microscopic examination of the
stained slide.
2. Numerical Assays
a) T and B subpopulations
This was performed as previously described under Methods.
b) Lymphocyte subpopulations identified by murine monoclonal
antibodies
This was performed as previously described under Methods.
3. Functional Assays
a) ConA induction of suppressor cells tested on a normal
homologous PHA transformation of lymphocytes
This was undertaken as previously described under Methods
b) MNC stimulation by Phytohaemagglutinin {PHA)
{i) � were obtained as described under MNC separation 
{ii) MNC concentration was adjusted to l,33xlo6 cells/ml with
culture medium+ 12,5% AB serum. The cells were dispensed in 
quadruplicate into each well of Titertek round bottomed 
microtitre plates as follows: 
434 . 
MNC 2xl0 6 lSOpl 
Culture medium 25pl 
PHA 0,4pg 25pl (This concentration has been
previously found to be optimal 
results not shown) 
Schematic diagram: 
Row number 2-5 7-10
B MNC+o MN:+PHA 
where 0 = culture medium. 
(iii) The outer rows of the plates were filled with sterile water to
prevent evaporation, it was covered with a lid and wrapped in
Jiffy wrap.
(iv) The plates were incubated at 37°c for a total of 3 days (this
incubation period has been found to be optimal for PHA
l�hocyte stimulation results not shown) and 
14c-Thyrnidine
(0,075pCi/lqil) was added 24 hours before the plates were 
harvested. 
(v) The plates were harvested as described under "Assay of




The results were expressed as dpm of the stimulated cultures as 
well as the stimulation index (SI) calculated as follows: 
= L'.ldpm of cultures with PHA 
Adpm of cultures without PHA 
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Statistical Analysis 
Results were analysed as described under methods, using the 
non-parametric Mann Whitney U test when comparing patients versus 
controls and patients with DMD versus patients with SMA. Correlation 
analysis was performed using the Spe�rman Rank correlation coefficient 
and significance was tested at th 5% level. 
RESULTS 
Surranary of Findings 
1) An increased number of OKT8+ cells and a redu::tion in proportions
of OKT4+ cells were found in DMD as compared to controls. 't'b
differences in irnrnunoregulatory cell nt.nnbers were detected in SMA
as compared to controls or within SMA patients according to
severity of disease.
2) Suppressor cell function and PHA transformation were normal in
coth groups of patients.
1) Numerical assays in I:MD and SMA (Table 63, Figure 99)
The absolute number of T-suppressor/cytotoxic cells as defined by 
rronoclonal antitody a<T8 were significantly elevated (p=0,035 3) in 
patients with DMD (1218 .±. 142 cells/rnrn3 mean .±. SEM) as compared to 
controls (815 + 95 cells/mrn3). OKT4+ subset expressed as a percentage
of OKT 3 was significantly redu::ed (p=0,0282) in patients (50% .±. 3) 
when compared to controls (61%+ 3). There were no significant 
deviations from normal in absolute rronocuclear cells, absolute 
lymphocytes, T cells (E-rosette and OKT3 .r-t:>Ab) Null and OKT4+ cells,
although these cells were consistently higher in I:MD, while the T4/T8 
ratio was lower. In SMA when compared to controls, or when compared 
to each other with respect to the degree of severity of disease, there 
were no differences in any of the atove numerical assays studied. 
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Table 63. Numbers of M::>nonuclear Cells, T cells and T cell subsets in CMD, 
SMA and their respective controls 
Cell Type











3909 + 386* 3190 + 275 4659 + 551 4785 + 50 
Absolute lymphocytes 3525 + 329 2815 + 254 4131 + 545 4343 + 51 
T cells (E-rosette technjque) 2293 + 220 1860 + 186 3145 + 407 2345 + 28 
B cells (Sig) 283 + 68 365 + 61 365 + 127 504 + 11 
Null cells 1366 + 249 902 + 104 1313 + 155 1827 + 28 
T cell (M::>noAb OKT3) 2370 + 234 1771 + 196 2510 + 417 2395 + 24 
OKT4 cells (T helper/indocer) 1172 + 127 1036 + 102 1403 + 258 1468 + 15 
OKT8 cells (T suppressor/ 
cytotoxic) 1218 + 142° 815 + 95 1202 + 206 1334· + 15 
% OKT4 of OKT3 so·+ 3° 61 + 3 56 + 5 62 + 3 
OKT8 of OKT3 52 + 3 48 + 3 49 + 3 56 + 3 
Ratio OKT4/0KT8 
* �an + SEM
1,03 _:: 0,09 1,34 _:: 0,10 1,18 + 0,14 1,18 _:: 0,10 
0 Individual p values are given in the text
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2) Functional assays in IMO and SMA (Table 64)
There was no difference detected in the T-suppressor cell activity as 
determined by ConA between p�tients and controls in both DMD and SMA. 
Similarly no difference was seen in the T-cell function as assayed by 
PHA between patients with each of the disorders and their- respective 
controls. 
3) Correlations
There was a significant correlation in both DMD patients (r=+o, 9CXX)) 
p<O,(X)()l) and their respective controls (r = +o,8596) (p < O,(X)()l) in 
the T-cell numbers detected by E-rosette technique and by rronoclonal 
antibody OKT3. Similar findings were obtained in SMA patients and 
their respective controls betwen T cells detected by E-rosette 
technique and by OKT3 rronoclonal antibody (r = + 0,8529 p < 0,CXX)l; 
r=+o,7696 p .s_ 0,(X)()2 respectively). 
There was no correlation between numerical and functional assays of 
T-suppressor cells in either the patient or control groups.
Table 64 T cell functional assays in I:MD and SMA patients 




18 + 5* 25 + 4 





23 + 8 17 + 5 
37 + 7 26 + 5 
% ruppression (ConA 5 pg) 
% suppression (ConA 30 pg) 
PHA Transformation- (dpm) 
Stimulation Index (SI) 
10192 + 1155 10557 + 691 9283 + 1992 12275 + 3697 




T-cells and/or their prodocts have been implicated in the inflarranatory
infiltrate and necrosis of muscle in disorders of the CNS where there
is muscle weakness eg. polymyositis, 
sclerosis (Da¼kins and Mastaglia, 19_73; 
et al., 1971; Skolnik et al.,. 1982) • 
dermatomyositis and multiple 
Bresnan et al., 1981; Santoli 
DMD a genetically determined 
disorder and SMA an a<X!uired sporadic disorder in southern Africa 
(.r.tx:>sa and Dawood, 1986) also are characterized by progressive muscle 
wasting and necrosis. 
In DMD, an abnormality in the ability of B cells to "cap" has been 
reported (Pickard et al., 1978; Ver ill et al., 1977), these results 
have been conflicting (Gershwin et al., 1979) and the derangements 
have been attributed to the cytoskeleton rather than to irranunity. 
Evidence of a cell-mediated irranune effector response against muscle 
fibre was shown in studies of the nature of the rrononuclear cell 
infiltrate in muscle biopsy specimens (Arahata and Engel, 1984). It 
has been shown (Arahata and Engel, 1984) in DMD, polymyositis and 
inclusion l::x:>dy myositis, that non-necrotic muscle fibres were invaded 
by TS+ cells, a lesser number of T4+ cells and macrophages and also 
those T cells expressing the Ia marker. This observation has been 
suggested to imply that there appears to be recognition of specific 
muscle fibre antigen by an antigen receptor on at least some of the 
invading T cells which had previously become sensitized to this 
putative antigen (Maritz et al., 1983). It could be that the antigen 
may be distributed in discrete sites. In SMA, however, several 
authors (Ryniewicz and Pawinska, 1978; Hausrnanova-Petruswicz and 
Fidzianska-Dolot 1984) have shown evidence that there was a decrease 
in 011 as assayed by skin testing (PPD) and PHA lymphocyte 
transformation. 
These findings prompted us to investigate the irranune status of these 
two disorders of muscle whether it may be affected rrore and/or less by 
the direct (as in the case of DMD) or indirect degeneration of muscle 
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(as in the case of SMA). The availability of rronoclonal antibodies to 
T-cells and certain functional tests of OU were used in order to 
observe whether the network of immune regulation was perhaps 
imbalanced as a result of muscle degeneration or vice versa. 
A significant increase in the number of T-suppressor/cytotoxic subset 
was found in DMD. Although,· no difference was observed in the number 
of QKT4+ cells, these cells when expressed as a percentage of the 
total 0KT3 cells were significantly decreased. The increase in the 
OKT8+ explains the decrease in the percentage of OKT4+ cells and the 
lower T4/T8 ratio observed. This elevation in the OKT8+ cells could 
be the way the immune response tries to dampen the continued 
sensitization of l:YITIPhocytes to muscle antigens. The increase in the 
OKT8+ subset contrasts with reports in polymyositis, dermatomyositis, 
multiple s::lerosis and myasthenia gravis where a redu::tion in the 
circulating '!'-suppressor subset has been demonstrated (Santoli et al., 
1971; S<olnik et al., 1982; Bresnan et al., 1981). On the other hand, 
Iyer et al. ·(1983) found normal numbers of T-cell subsets in the first 
two conditions. The difference in our findings and those reported in 
polymyositis, multiple s::lerosis and myasthenia may be explained by 
the fact that these are primarily immune mediated a�uired conditions, 
whereas DMD is a genetic disorder in which the primary defect is 
thought to reside in the muscle membrane. 
There was an increase, although not significantly from controls, in 
the absolute number of rrononu::lear cells and l:YITIPhocytes, in T-cells 
as detected by the E-rosette technique and by rronoclonal antibody 
(0KT3), in Null cells and T helper/indu::er cells. The higher number 
of total T cells probably reflects suppressor/cytotoxic cell increase. 
B cell numbers, although not significantly redu::ed as compared to 
controls, were lower. This decrease could be due, as previously 
suggested by Pickard et al. (1978) , to changes in the conformational 
structure of the B l:YITIPhocyte which result in an altered membrane 
fluidity, thereby rendering the detection of surface irnmunoglobulin 
difficult by conventional tests. 
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T-suppressor cell function by pre-treatment with ConA·did not show any
increase in suppressor cell activity as would have been expected from
the elevated OKT8+ cell numbers in DMD. These discrepancies may be
explained by the fact that one cannot separate the cytotoxic and
suppressor aspect of T cells_ using a<T8 antibody. An increase in the
number of OKT8+ cells may in fact be due to an elevated number of
cytotoxic cells enumerated in the OKT8+ subset. If this. is in fact
so, .it could exp la in our results of normal function of suppressor
cells. Furthermore, the ConA test is a non specific measure of
suppressive activity and may therefore not reflect any antigen
determined reactions in DMD. The reasons for the lack of correlation
between alteration in lymphocyte subset numbers with lymphocyte assays
of either help or suppression have already been given. (See Chapter on
Measles). As the nonoclonal antibodies are mt.eh nore accurate in this
regard, we would suggest that there is likely to be increased
suppressor activity in DMD. The normal lymphocyte response to PHA
adds further evidence to the normal overall T cell function in DMD;
any defect is likely to be highly antigen specific.
Patients with SMA showed no abnormalities in either immunoregulatory 
cell number or function compared to controls. Similar findings were 
obtained arrong SMA patients with respect to severity of disease. 
These findings differ from those of Ryniewicz and Pawinska (1978) who 
showed a significant decrease in the transformation of lymphocytes to 
PHA in children with SMA regardless of severity. These authors 
suggested that the decrease in OH may be due to congenital defect of 
the thymus. These discrepancies may be explained by the fact that SMA 
in Africa, is a sporadic disease (M::x)sa and Dawcod, 1986) unlike in 
Europe and Asia where it is inherited as an autosomal recessive 
disorder. The pathogenesis might also be different (M::x)sa and Dawcod, 
1986). 
In summary, this study suggests that the direct degeneration of muscle 
in DMD is associated with regulatory changes in the number of cells of 
the irranune system. It could be that, the genetic determinant which 
causes active muscle degeneration releases muscle antigen which in 
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turn continuously causes lymphocyte sensitization follo�d by release 
of tissue damaging lymphokines which exert a cytotoxic effect (Johnson 
et al., 1972) • This process is dampened by an increase in the 
suppressor/cytotoxic population of the immunoregulatory net-...ork. A 
decrease in the percentage of T helper/indocer population is probably 
a secondary effect. This ·postulated mechanism -...ould be further 
supported from the ....erk of Arahata and Engels (1984) who. postulated 
that the Class I major histoco�atibility complex (M:H) gene prodoct 
expressed on muscle fibres is likely to be the triggering factor for 
recognition by T8+ cells. Ho�ver, � recognize the limitations of 
making comparisons with results from different latoratories in 
different settings. Lymphokines, which may also be cytotoxic (Johnson 
et al., 1972) are released by sensitized cells which in turn recruit 
T4+ cells and macrophages, with the former cells augmenting the 
activity of the cytotoxic T8+ cells (Reinherz et al, 1979). It may be 
that this imbalance leads to the abnormality in the cytoskeleton of 
the muscle membrane reported in this disorder. Although the atove are 
possibilities, one cannot place too moch emphasis on the functional 
significance of lymphocyte phenotypic profile. It has been shown that 
toth T4+ and T8+ subpopulations are functionally heterogeneous and 
T4+ cells may contain subpopulations that are helper/indocer, indoce 
T8+ precursors to become suppressor cells and express cytotoxic 
activity against cells bearing Class II antigens (Young and Geha, 
1986). 
Unlike DMD, SMA is a slow process of muscle wastage where the 
degeneration of muscle is secondary to a defect in the anterior horn 
cell of the spinal cord. Hence lymphocytes may not be actively 
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Table 6 Comparison between light and heavy S.haematobium infections 
for all parameters 
Group 4 A =  Light SH B = M:)derate - Heavy SH 
Light SM Light - r.bderate SM 
Group 4 Group 4 
B 
Absolute Number 23 11 
rrononuclears Mean 4008 4300 
cells/nun3 SD 1305 1527 
SEM 272 460 
Min 897 2240 
Max 5890 7344 
Range 4993 5104 
Absolute Number 23 11 
Lymphocytes Mean 3628 3768 
cells/nun3 SD 1280 1543 
SEM 267 465 
Min 780 1840 
Max 5670 6885 
Range 4890 5045 
T cell Number 20 11 




SEM 227 404 
Min 1775 1859 
Max 5132 6462 
Range 3357 4603 
B cells Number 20 11 
(Sig) Mean 487 505 
cells/nun3 SD 274 268 
SEM 61 81 
Min 76 203 
Max"', 1211 1013 
Range 1135 810 
Group 4 Group 
B 
Null cells Number 20 11 
cells/mm3 Mean 371 299 
SD 402 289 
SEM 90 87 
Min . 73 31 
Max 1473 1016 
Range 1400 985 
FT cells Number 20 11 
cells/mm3 Mean 10 0 
SD 26 0 
SEM 6 0 
Min 0 0 
Max 96 0 
Range 96 0 
T cells · Number 20 11 
(0KT3r.bAB) Mean 2461 1761 
cells/mm3 SD 830 539 
SEM 186 163
Min 1235 911 
Max 3887 2541 
Range 2652 1630 
T Helper/in- Number 20 11 
du:::er cells Mean 984 513
cells/mm3 SD 567 445 
SEM 127 134 
Min 140 0 
Max 2264 1386 
Range 2124 1386 
Group 4 Group 4 
A B 
T suppressor/Number 20 11 
cytotoxic Mean 1318 1034 
cells SD 657 724 
ce lls/rrun3 SEM 147 218 
Min 618 538 
Max 3616 3011 
Range 2998 2473 
% OKT4 of Number 20 11 
OKT3 Mean 43 29 
SD 22 24 
SEM 5 7 
Min 5 0 
Max 99 59 
Range 94 59 
% OKT8 of Number 20 11 
OKT3 Mean 55 59 
SD 14 28 
SEM 3 8 
Min 32 29 
Max 94 121 
Range 62 92 
Ratio OKT4/ Number 20 11 
OKT8 Mean 0,84 o, 7 
SD 0,48 0,67 
SEM 0,11 0,20 
Min 0,07 0 
Max 2,07 1,88 
Range 2 1,88 
Group 4 Group 4 
A B 
wee Number 23 11 
X 109/L Mean 8,35 9,56 
SD 2,68 3, 56 
SEM 0,56 1,07 
Min 3,9 6 
Max 15,5 15,4 
Range 11,6 9,4 
% Neutro- Number 23 11 
phils Mean 35 39
SD 14 12,79
SEM 3 3,86 
Min 15 16 
Max 70 58 
Range 55 42 
% Lyrnpho- Number 23 11 
cytes Mean 45 40 
SD 14 10 
SEM 3 3 
Min 20 23 
Max 70 57 
Range so 34 
% M:mocytes Number 23 11 
Mean 4 6 
SD 2 3 
SEM 0,34 0,78 
Min 1 3 
Max 8 10 
Range 7 7 
Group 4 Group 4 
B 
F.osinophils Number 23 11 
% Mean 16 15 
SD 9 7 
SEM 2 2 
Min 0 6 
Max 33 30 
Range 33 24 
Basophils Number 23 11 
Mean 2 0 
SD 10 0 
SEM 2 0 
Min 0 0 
Max 50 0 
Range 50 0 
Sen.nn Number 20 11 
IgA Mean 255 215 
mg/dL SD 163 55 
SEM 36 17 
Min 73 146 
Max 837 329 
Range 764 183 
IgM Number 20 11 
rng/dL Mean 252 335 
SD 127 121 
SEM 28 37 
Min 55 233 
Max 510 670 
Range 455 437 
Group 4 Group 4 
A B 
IgG Number 20 11 
mg/dL Mean 2369 2100 
SD 998 323 
SEM 223 97 
Min 1355 1659 
Max 5891 2651 
Range 4536 992
Complement Number 15 11 
C3 Mean 93 128 
�/dL SD 42 38 
SEM 11 11 
Min 5 89 
Max 166 232
Range 161 143 
Rbc Number 23 11 
X 1012/L Mean 4,22 4,54 
SD o,87 0,24 
SEM 0,18 0,07 
Min 0,53 4,16 
Max 5,08 4,86 
Range 4,55 o, 7 
Hb Number 23 11 
g/dL Mean 12,3 11,81
SD 0,98 o, 77 
SEM 0,20 0,23 
Min 9,8 10,6 
Max 13,9 13, 3 
Range 4,1 2,7 
Group 4 Group 4 
A B 
M:V Number 23 11 
f/L Mean 333 89,81 
SD 377 7, 56 
SEM 76 2,27 
Min 79 81 
Max 944 101 
Range 865 20 
Platelets Number 9 Missing value 






Bicx::hemical . Number 23 11 
Albumin Mean 40 39 
g/L SD 8 
,.., 
SEM 1,68 1,27 
Min 11 31 
Max 50 45 
Range 39 14 
AST Number 22 11 
U/L Mean 22 16 
SD 6,62 6,19 
SEM 1,41 1,86 
Min 8 8 
Max 33 28 
Range 25 20 
Group 4 Group 4 
A B 
Plasma Number 13 11 
Zinc Mean 0,88 0,92 
um/L SD 0,44 0,32 
SEM 0,12 0,10 
Min 0,38 0,60 
Max 2,11 1,70 
Range J-, 73 1,1 
Total Number 15 11 
Globulins Mean 33,67 32,91 
g/L SD 6,96 4,91 
SF.M 1,80 1,48 
Min 20 27 
Max 49 41 
Range 29 14 
Plasma Number 14 10 
Creatinine Mean 37 36 
rmol/L SD 10,86 12,67 
SEM 2,90 4,00 
Min 9 3 
Max 54 46 
Range 45 43 
Parasitology 
Egg Count Number 13 11 
in Urine Mean 17 520 
(Repeat) SD 29 867 
S.Haem) SEM 8 261 
Min 0 0 
Max 90 2916 
Range 90 2916 
Group 4 Group 4 
A B 
Egg count Number 20 11 
in stool Mean 8 24 
before SD 14 56 
SEM 3 17 
Min 0 0 
Max 45 190 
Range 45 190 
Nutritional 
Age Number 23 11 
Mean 10,70 9,91 
SD 1,79 2,26 
SEM 0,37 0,68 
Min 7 7 
Max 13 13 








Table 7 Comparison of immunological parameters between relapse and remission in 
MCNS 
Absolute Mononuclears Number 






Absolute Lymphocytes Number 






T cells (E-rosette) Number 






B cells (Sig) Number 



































M:NS in relapse + 





























MCNS in relapse + 
M:NS remission Partial remission P value 
% T suppressor cell Number 14 13 
function ConA 5 Mean 30 17 
SD 29 23 0,4374 




% T suppressor cell Number 15 14 
function ConA 30 Mean 31 38 
SD 18 24 0,4985 
SEM 4 7 
Min -1 2 
Max 57 81 
Range 58 79
PWM (dpn) Number 9 12 
Mean 4970 5010 
SD 2362 3098 0,6440 
SEM 787 894 
Min 500 219
Max 8279 9047 
Range 7779 8828 
vl:C X 109/1 Number 16 15 
Mean 7,96 11,50 
SD 2,38 5,09 0,0296* 
SEM 0,59 1,31 
Min 5,20 5,00 
Max 13,40 21,40 
Range 8,20 16,40 
M:NS in relapse + 
M:NS remission Partial remission P value 
% Neutrophils Number 16 15 
Mean 50 46 
SD 11 14 0,2508 
SEM 2 4 
Min .33 22 
Max 70 81 
Range 37 59 
% Lym phocytes Number 16 15 
Mean 37 43 
SD 9 11 0,0749 
SEM 2 3 
Min 19 16 
Max 59 60 
Range 40 44 
% Monocytes Number 16 15 
Mean 6 4 
SD 3 3 0,1406 
SEM o, 75 0,69 
Min 2 1 
Max 12 9 
Range 10 8 
% Eos inoph il s Number 16 15 
Mean 4 5 
SD 4 5 0,9045 
SEM 1 1 
Min 1 0 
Max 16 21 
Range 15 21 
M:NS in relapse + 
M:NS remission Partial remission P value 
% Basophils Number 16 15 
Mean 0,43 0,49 
SD 0,62 0,83 0,8509 
SEM 0,15 0,21 
Min 0 0 
Max 2 3. 
Range 2 3 
% Atypical Lymphocytes Number 16 15 
Mean 0,25 0,93 
SD l 1,75 0,0755 
SEM 0,25 0,45 
Min 0 0 
Max 4 6 
Range 4 6 
% Others Number 16 15 
Mean 0 0 
SD 0 0 0,CXX)l* 
SEM 0 0 
Min 0 0 
Max 0 0 
Range 0 0 
Table 8 Corrparison of irranunological parameters between controls and patients 
with M:NS with respect to clinical condition 
RM = remission PR = Partial remission R = Relapse 
M:NS = Minimal change nephrotic syndrome 
M:NS,RM p M:NS p 
Parameters Controls Value Controls PR, R Value 
Absolute Number 17 16 17 15 
rrononuclears Mean 3553 3556 0,9426 4194 - 5514 0,3451 
cells/rran3 SD 1407 1534 1228 2782
SFM 341 384 298 718 
Min 1290 1988 2100 2457 
Max 6532 8174 6588 10740 
Range 5242 6186 4488 8283
Absolute Number 17 16 17 15 
Lymphocytes Mean 3199 3085 0,4712 3823 4935 0,3955 
ce lls/rran3 SD 1301 1564 1079 2434 
SFM 315 391 262 628 
Min 903 1716 1680 2096 
Max 5822 7906 5856 9666 
Range 4919 6190 4176 7570 
T cell Number 17 13 17 14 
(E-rosette) Mean 1989 2219 0,9167 2515 3827 0,0955 
ce lls/rran3 SD 940 1391 894 1944 
SFM 228 386 217 520 
Min 284 1065 945 1400 
Max 4005 6294 4612 7088 
Range 3721 5229 3667 5688 
B cells Number 17 13 17 14 
(Sig) Mean 378 179 0,0180* 463 324 0,2335 
ce lls/rran3 SD 256 154 436 390 
SFM 62 43 106 104 
Min 42 0 0 0 
Max 1078 531 1643 1438 
Range 1036 531 1643 1438 
MCNS,RM p MCNS p 
Parameters Controls Value Controls PR, R Value 
Null cells Number 17 13 17 14 
ce lls/rran3 Mean 1178 1092 0,8835 1158 1484 0,4998 
SD 770 496 600 988 
SEM 187 138 145 264 
Min 68 437 94 497 
Max 2825 1923 2228 3438 
Range 2757 1486 2134 2941 
FT cells Number 17 13 17 14 
ce lls/rran3 Mean 7 3 0,4571 8 21 o, 7334 
SD 19 10 25 55 
SEM 5 3 6 15 
Min 0 0 0 0 
Max 76 37 88 186 
Range 76 37 88 186 
T cells Number 17 16 17 15 
( 0KT 3.r-bAb) Mean 1937 1951 0,6525 2491 3091 o, 3955 
cells/rran3 SD 709 867 985 1875 
SEM 172 217 239 484 
Min 542 934 1094 846 
Max 3132 3842 4874 8055 
Range 2590 2908 3780 7209 
T Helper/in- Number 17 16 17 15 
docer cells Mean 1291 1135 0,2641 1601 1459 0,4168 
ce lls/rran3 SD 448 476 526 788 
SEM 109 119 128 203 
Min 297 354 781 493 
Max 2025 2125 2701 3007 
Range 1728 1771 1920 2514 
M:NS,RM p MCNS p 
Parameters Controls Value Controls PR, R Value 
T suppressor/Number 17 16 17 15 
cytotoxic Mean 896 1042 0,5403 1142 1699 0,0759 
cells SD 420 552 425 884 
cells/rrun3 SEM 102 138 103 228 
Min 271 457 483 398 
Max 1764 2616 1850 . 3007 
Range 1493 2159 1367 2609 
% 0KT4 of Number 17 16 17 15 
0KT3 Mean 67 60 0,1652 66 50 0,0011* 
SD 9 16 12 14 
SEM 2 4 3 3 
Min 55 34 49 31 
Max 81 90 100 84 
Range 26 56 51 53 
% 0KT8 of Number 17 16 17 15 
0KT3 Mean 46 54 0,0381* 47 59 0,0638 
SD 10 10 10 18 
SEM 2 3 2 5 
Min 29 38 29 31 
Max 67 78 67 96 
Range 38 40 38 65 
Ratio CKT4/ Number 17 16 17 15 
CKT8 Mean 1,54 1,18 0,0335* 1,48 0,93 0,CXX>6* 
SD 0,38 0,40 0,44 0,41 
SEM 0,09 0,10 0,11 0,10 
Min 0,97 0,44 1,03 0,33
Max 2,29 1,79 2,75 2,04 
Range 1,32 1,35 1, 72 1, 71 
M:NS,RM p M:NS p 
Parameters Q:)ntrols Value Controls PR, R Value 
% suppressor Number 15 14 16 13 
cell func- Mean 31 30 0,6943 32 17 0,0913 
tion ConA 5 SD 22,89 29,83 18,97 23 
SEM 5,91 7,97 4,74 6 
Min -4 -2 1 -21
Max 79 J.02 70 55
Range 83 104 69 76
% suppressor Number 16 15 16 14 
cell func- Mean 38,44 31,33 0,2680 37,31 38 0,9172 
tion ConA 30 SD 26,03 18,41 19, 77 24 
SEM 6,51 4,75 4,94 7 
Min -28 -1 5 2 
Max 86 57 65 81 
Range 114 58 60 79 
PWM (dpm) Number 10 9 13 12 
�an 6408 4970 0,2207 6174 5010 0,7856 
SD 3393 2362 2709 3098 
SEM 1073 788 751 894 
Min 642 500 2685 219
Max 12520 8280 11924 9047 
Range 11878 7780 9239 8828 
wee Number 17 16 17 15 
X 109/L Mean 8,54 7,97 0,7456 9,20 11,50 0,1622 
SD 3,20 2,39 3,49 5,09
SEM 0,78 0,58 0,85 1,31 
Min 4,30 5,20 5,20 5,00 
Max 16,60 13,40 18,30 21,40 
Range 14,30 8,20 18.30 16,40 
M:NS,RM p M:NS p 
Parameters Controls value Controls PR, R Value 
% Neutro- Number 17 16 17 15 
phils �an 52 51 0,6915 47 46 0,4725 
SD 11 11 11 14 
SEM 3 3 3 4 
Min 31 33 23 22 
Max 70 70 68 81 
Range 39 37 45 59 
% Lyrnpho- Number 17 16 17 15 
cytes �an 38 38 0,8995 43 43 0,8649 
SD 12 10 11 11 
SEM 3 2 3 3 
Min 21 19 24 16 
Max 62 59 62 60 
Range 41 40 38 44 
% MJnocytes Number 17 16 17 15 
�an 4 6 0,0986 4 4 0,7442 
SD 2 3 2 3 
SEM 0,51 o, 76 0,40 0,69 
Min 1 2 1 1 
Max 9 12 6 9 
Range 8 10 5 8 
% Eosino- Number 17 16 17 15 
phils �an 5 5 0,8414 5 5 0,9089 
SD 5 4 5 5 
SEM 1 1 1 0 
Min 0 1 1 0 
Max 15 16 21 21 
Range 15 15 20 21 
M:NS,RM p M:NS p 
Parameters Controls Value Controls PR, R Value 
% Basophils Number 17 16 17 15 
Mean 0,06 0,43 0,0275* 0,41 0,47 0,8712 
SD 0,24 0,63 0,71 0,83 
SEM 0,06 . 0,16 0,17 0,21 
Min 0 0 0 0 
Max 1 2 2 3 
Range 1 2 2 3 
% Atypical Number 17 16 17 15 
lymphocytes Mean 0,29 0,25 0,6388 0,35 0,93 o, 4313 
SD 0,85 1 o, 70 1,75 
SEM 0,21 0,25 0,17 0,45 
Min 0 0 0 0 
Max 3 4 2 6 
Range 3 4 2 6 
% Others Number 17 16 17 15 
Mean 0 0 O,<XXH* 0 0 O,CXX)l* 
SD 0 0 0 0 
SEM 0 0 0 0 
Min 0 0 0 0 
Max 0 0 0 0 
Range 0 0 0 0 
Table 9 Corrparison of irranunological parameters between controls and membranous 
group of nephrotic syndrome with respect to clinical condition 
ME= Membranous RM= Remission PR= Partial Remission R = Relapse 
ME, RM p ME, PR p 
Controls PR, R Value Controls R Value 
Absolute Number 14 14 13 13
rrononuclears Mean 3265 4387 0,0482 
* 
3276 4359 0,0858 
ce lls/rran3 SD 1095 1616 1139 1679 
SEM 293 432 316 466 
Min 1440 1428 1440 1428 
Max 5550 7770 5550 7770 
Range 4110 6342 4110 6342 
Absolute Number 14 14 13 13
Lymphocytes Mean 3035 3657 0,2148 3034 3579 0,3173
cells/rran3 SD 981 1475 1021 1505 
SEM 262 394 283 417 
Min 1332 1020 1132 1020 
Max 4884 6660 4884 6660 
Range 3552 5640 3752 5640 
T cell Number 14 14 13 13 
(E-rosette) Mean 1847 3010 0,0308* 1838 2997 0,0483* 
cells/rnm3 SD 593 1732 616 1802 
SEM 159 463 171 500 
Min 749 457 749 457 
Max 2722 6760 2722 6760 
Range 1973 6303 1973 6303
B cells Number 14 14 13 13 
(Sig) Mean 401 190 0,0274* 410 164 0,0111* 
ce lls/rran3 SD 366 143 379 111 
SEM 98 38 105 31 
Min 86 0 86 0 
Max 1591 524 1591 385 
Range 1505 524 1505 385 
ME, RM p ME, PR p 
Controls PR, R Value Controls R Value 
Null c"ells Number 14 14 13 13 
cells/mm3 Mean 951 1178 0,3827 957 1188 0,3695 
SD 613 692 638 719 
SF.M 164 185 177 199 
Min 302 547 302 547 
Max 2719 2706 2719 2706 
Range 2417 2159 2417 2159 
FT cells Number 14 14 13 13 
cells/mm3 M:an 8 9 l,(XXX) 9 10 l,CXXX) 
SD 24 25 25 25 
SF.M 6 7 7 7 
Min 0 0 0 0 
Max 88 78 88 78 
Range 88 78 88 78 
T cells Number 13 14 12 13 
(0KT3MJAb) Mean 1861 2691 0,0225* 1902 2671 0,0502 
cells/mm3 SD 536 1192 539 1238 
SF.M 149 319 156 343
Min 691 443 691 443
Max 2459 5051 2459 5051 
Range 1768 4608 1768 4608 
T Helper/in- Number 13 14 12 13 
du::er cells Mean 1106 1345 0,1594 1107 1324 0,2534 
cells/mm3 SD 350 644 365 665 
SF.M 97 172 105 184 
Min 619 243 619 243 
Max 1944 2376 1944 2376 
Range 1325 2133 1325 2133
ME, RM p ME, PR p 
Controls PR, R Value Controls R Value 
T suppressor/Number 13 14 12 13 
cytotoxic Mean 827 1448 0,0039* 836 1442 0,0083* 
cells SD 249 799 258 831 
ce lls/rrnn3 SEM 69 214 74 231 
Min 273 214 273 214 
Max 1061 3341 1061 3341 
Range 788 3127 788 3127 
% OKT4 of Number 13 14 12 13 
OKT3 Mean 62 51 0,2636 60 51 o, 3832 
SD 16 14 15 14 
SEM 4 4 4 4 
Min 44 26 44 26 
Max 90 70 90 70 
Range 46 44 46 44 
% OKT8 of Number 13 14 12 13 
OKT3 Mean 45 54 0,4512 45 54 0,4622 
SD 12 23 12 24 
SEM 3 6 3 7 
Min 20 15 20 15 
Max .66 110 66 110 
Range 46 95 46 95 
Ratio OKT4/ Number 13 14 12 13 
OKT8 Mean 1,43 1,05 0,0466* 1,42 1,05 0,0508 
SD 0,46 0,51 0,48 0,54 
SEM O,13 0,14 0,14 O,15 
Min 0,74 0,33 0,74 0,33 
Max 2,43 2,22 2,43 2,22 
Range 1,69 1,89 1,69 1,89 

ME, RM p ME, PR 
Controls PR, R Value Controls R Value 
% Neutro- Number 14 14 13 13 
phils Mean 53 58 0,4201 53 59 0,2078 
SD 9 14 9 13 
SEM 2 4 3 4 
Min 41 40 41 40 
Max 70 92 70 92 
Range 29 52 29 52 
% Lympho- Number 14 14 13 13 
cytes Mean 41 30 0,0106* 41 28 0,0034* 
SD 9 12 9 10 
SEM 2 3 2 3 
Min 28 5 28 5 
Max 54 55 54 44 
Range 26 50 26 39 
% M:mocytes Number 14 14 13 13 
Mean 3 6 0,0131* 3 6 0,0065* 
SD 2 3 2 3 
SEM 0,49 0,90 0,50 0,89 
Min 1 1 1 2 
Max 7 13 7 13 
Range 6 12 6 11 
% F.osino- Number 14 14 13 13 
phils Mean 2 6 0,0965 2 6 0,1250 
SD 3 8 3 8 
SEM 0,85 2 0,90 2,23 
Min 0 0 0 0 
Max 10 30 10 30 
Range 10 30 10 20 
ME, RM p ME, PR 
Controls PR, R Value Controls R Value 
% Basophils Number 14 14 13 13 
Mean 0,14 0,71 0,9590 0,15 0,08 0,9558 
SD 0,53 0,27 0,55 0,28 
SEM 0,14 0,07 0,15 0,08 
Min 0 0 0 0 
Max 2 1 2 1 
Range 2 1 2 1 
% Atypical Number 14 14 13 13 
lymphocytes Mean 0 0 O,COOl* 0 0 O,CCOl* 
SD 0 0 0 0 
SEM 0 0 0 0 
Min 0 0 0 0 
Max 0 0 0 0 
Range 0 0 0 0 
% Others Number 14 14 13 13 
Mean 0 0 O,COOl* 0 0 O,COOl* 
SD 0 0 0 0 
SEM 0 0 0 0 
Min 0 0 0 0 
Max 0 0 0 0 
Range 0 0 0 0 
Table 10 Comparison of immunological parameters between controls and 
Proliferative group of nephrotic syndrome with respect to clinical condition 
Prol. = Proliferative Rem. = remission PR = Partial remission R = Relapse 
Prol.Rem. p Prol. p 
Controls PR, R Value Controls PR, R. Value 
Absolute Number 11 9 9 8 
rrononuclears Mean 3599 5131 0,0874 3773 · 5558 0,0675 
cells/rnm3 SD 1993 1900 2159 1504
SEM 601 633 720 532 
Min 1290 1725 1290 3128 
Max 7406 8120 7406 8120 
Range 6116 6395 6116 4992 
Absolute Number 11 9 9 8 
Lymphocytes Mean 3238 4407 0,1837 3348 4786 0,1779 
cells/rnm3 SD 1949 1764 2049 1443 
SEM 587 588 683 510 
Min 903 1380 903 2788 
Max 6762 7308 6762 7308 
Range 5859 5928 5859 4520 
T cell Number 11 9 9 8 
(E-rosette) Mean 2290 3331 0,1024 2373 3642 0,0675 
cells/rnm3 SD 1436 1405 1578 1124 
SEM . 433 468 526 397 
Min 284 845 284 1814 
Max 4814 5071 4814 5071 
Range 4530 4226 4530 3257 
B cells Number 11 8 9 7 
(Sig) Mean 327 160 0,2831 341 181 0,4914 
cells/rnm3 SD 322 125 357 121 
SEM 97 44 119 46 
Min 16 0 16 0 
Max 1037 325 1037 325 
Range 1021 325 1021 325 
Prol.Rern. p Prol. 
Controls PR, R Value Controls PR, R. Value 
Null cells Number 11 9 9 8 
cells/rnm3 Mean 894 1664 0,0527 1049 1765 0,1019 
SD 559 1129 489 1164 
SEM 169 376 163 411 
Min 94 716 232 716 
Max 1699 4466 1699 4466 
Range 1605 3750 1467 3750 
FI' cells Number 11 9 9 8 
cells/rnrn3 Mean 9 0 0,0990 9 0 0,1693
SD 18 0 20 0 
SEM 5 0 7 0 
Min 0 0 0 0 
Max 56 0 56 0 
Range 56 0 56 0 
T cells Number 11 9 9 8 
(0KT3MoAb) Mean 1844 2956 0,0527 1837 3176 0,0269* 
cells/rnm3 SD 1009 1290 1076 1184 
SEM 304 430 359 419 
Min 542 1190 542 1478 
Max 3699 5197 3699 5197 
Range 3157 4007 3157 3719 
T Helper/in- Number 11 9 9 8 
docer cells Mean 1139 1392 0,4250 1156 1476 0,3359 
cells/rnm3 SD 565 619 590 605 
SEM 170 206 197 214 
Min 297 438 297 438 
Max 1962 2192 1962 2192 
Range 1665 1754 1665 1754 
Prol.Rem. p Prol. p 
Controls PR, R Value Controls PR, R. Value 
T suppressor/Number 11 9 9 8 
cytotoxic Mean 883 1507 0,0627 936 1626 0,0675 
cells SD 538 786 585 748 
cells/mrn3 SEM 162 262 195 265 
Min 248 552 248 672 
Max 1850 2761 1850 2761 
Range 1602 2209 1602 2089 
% 0KT4 of Number 11 9 9 8 
0KT3 Mean 63 47 0,0250* 65 48 0,0432* 
SD 12 15 12 16 
SEM 3 5 4 6 
Min 52 25 53 25 
Max 86 73 86 73 
Range 34 48 33 52 
% OKT8 of Number 11 9 9 8 
0KT3 Mean 47 56 0,3805 49 58 0,4680 
SD 10 20 9 21 
SEM 3 7 3 8 
Min 29 31 38 31 
Max 66 90 66 90 
Range 37 59 28 59 
Ratio 0KT4/ Number 11 9 9 8 
0KT8 Mean 1,39 1,10 >0,05 1,35 1,07 0,1390 
SD 0,36 0,56 0,32 0,60 
SEM 0,11 0,19 0,11 0,21 
Min 0,97 0,30 0,97 0,30 
Max 2,05 2,05 1,81 2,05 
Range 1,08 1,75 0,84 1,75 
Prol.Rem. p Prol. 
Controls PR, R Value Controls PR, R. Value 
% suppressor Number 9 8 7 7 
cell func- Mean 32 27 0,7727 33 22 0,5649
tion ConA 5 SD 20 32 23 31 
SEM 7 11 9 12 
Min 10 -32 10 -32
Max 67 60 67 57
Range 57 92 57 89
% suppressor Number 10 8 8 7 
cell func- Mean 42 37 0,4767 46 31 0,1828 
tion ConA 30 SD 23 25 25 19
SEM 7 9 9 7 
Min 14 4 14 4 
Max 95 79 95 67 
Range 81 75 81 63 
PWM (dpm) Number 8 6 6 6 
Mean 7301 5660 0,2453 6810 5660 0,4233 
SD 3152 1387 2965 1388 
SEM 1115 567 1210 567 
Min 3175 4262 3175 4262 
Max 11924 7501 11279 7501 
Range 8749 3239 8104 3239
wee Number 11 9 9 8 
X 109/L Mean 7,79 11,68 0,0366* 8,10 12,28 0,0342* 
SD 3,44 3,56 3, 72 3,28 
SEM 1,04 1,19 1,23 1,16 
Min 4,30 6,80 4,30 6,80 
Max 16,10 16,00 16,10 16,CO 
Range 11,80 9,20 11,8 9,20 
Prol.Rem. p Prol. 
Controls PR, R Value Controls PR, R. Value 
% Neutro- Number 11 9 9 8 
phils M:an 54 49 o, 3599 55 46 0,1354 
SD 12 15 13 12 
SEM 4 5 4 4 
Min 32 26 32 26 
Max 70 75 70 64 
Range 38 49 38 38 
% Ly mpho- Number 11 9 9 8 
cytes Mean 41 38 0,5176 40 40 0,9615 
SD 12 12 13 11 
SEM 4 4 4 4 
Min 21 20 21 24 
Max 62 63 62 63 
Range 41 43 41 39 
% M:Jnocytes Number 11 9 9 8 
Mean 4 4 0,4824 4 4 0,9218 
SD 2 3 2 3 
SEM o, 70 0,90 0,81 l 
Min l 2 l 2
Max 9 10 9 10
Range 8 8 8 8 
% F.osino- Number 11 9 9 8 
phils Mean 2 8 0,0526 0,66 9 0,0023* 
SD 3 11 0,87 11 
SEM 0,92 4 0,29 4 
Min 0 0 0 l 
Max 10 32 2 32 
Range 10 32 2 32 
Prol.Rern. p Prol. p 
Controls PR, R Value Controls PR, R. Value 
% Basophils Number 11 9 9 8 
Mean 0,10 0,11 0,8839 0,11 0,13 0,9314 
SD 0,30 0,33 0,33 0,35 
SEM 0,09 - 0,11 0,11 0,13 
Min 0 0 0 0 
Max 1 1 1 1 
Range 1 1 1 1 
% Atypical Number 11 9 9 8 
lymphoci tes Mean 0,18 0 o, 3657 0,22 0 0,3458 
SD 0,60 0 0,67 0 
SEM 0,18 0 0,22 0 
Min 0 0 0 0 
Max 2 0 2 0 
Range 2 0 2 0 
% Others Number 11 9 9 8 
Mean 0 0,33 0,2689 0 0,38 0,2888 
SD 0 1 0 1,06 
SEM 0 0,33 0 0,38 
Min 0 0 0 0 
Max 0 3 0 3 
Range 0 3 0 3 
Table 11 Corrparison of immunological parameters between controls and 
Miscellaneous group of nephrotic syndrome with respect to clinical condition 
M = Miscellaneous RM= Remission PR = Partial Remission R = Relapse 
M, RM p M p 
Controls PR, R Value Controls PR, R. Value 
Absolute Number 11 10 9 8 
rrononuclears Mean 3248 3918 0,3242 3427 . 4034 0,3865 
cells/rnm3 SD 1132 �033 1184 2271 
SEM 341 643 395 803
Min 1551 546 1551 546 
Max 5605 6854 5605 6854 
Range 4054 6308 4054 6308 
Absolute Number 11 10 9 8 
Lymphocytes Mean 2984 3363 0,4813 3168 3414 0,5637 
cells/rnm3 SD 1013 1836 1036 2069 
SEM 305 580 345 732 
-Min 1504 420 1504 420 
Max 5130 6556 5130 6556 
Range 3626 6136 3626 6136 
T cell Number 11 9 9 8 
(E-rosette) Mean 1852 2752 0,5184 2007 2851 0,7003 
cells/rnm3 SD 658 2001 624 2115 
SEM 198 667 208 748 
Min 1046 399 1224 399 
Max 3251 6374 3251 6374 
Range 2205 5975 2027 5975 
B cells Number 11 9 9 8 
(Sig) Mean 340 124 0,0364* 381 102 0,0206* 
cells/rnm3 SD 253 138 261 131 
SEM 76 46 87 46 
Min 16 0 16 0 
Max 785 376 785 376 
Range 769 376 769 376 
M, RM p M p 
Controls PR, R Value Controls PR, R. Value 
Null cells Number 11 9 9 8 
cells/rnm3 Mean 1050 1031 0,6761 1031 1075 0,8474 
SD 465 817 497 861 
SEM 140 272 166 304 
Min 232 104 232 104 
Max 1601 2728 1601 2728 
Range 1369 2624 1369 2624 
FI' cells Number 11 9 9 8 
cells/mrn3 Mean 5 3 0,5015 6 3 0,5628 
SD 17 8 18 8 
SEM 5 3 6 3 
Min 0 0 0 0 
Max 56 23 56 23 
Range 56 23 56 23 
T cells Number 11 10 9 8 
(OKT3f>bAb) Mean 1834 2222 0,5493 1948 2240 o, 7361 
cells/mm3 SD 915 1174 983 1317 
SEM 276 371 328 465 
Min 605 333 605 333 
Max 3699 3699 3699 3699 
Range 3094 3366 3094 3366 
T Helper/in- Number 11 10 9 8 
du::er cells Mean 1083 1160 0,8880 1123 1233 0,9233 
cells/mm3 SD 494 799 544 888 
SEM 149 253 181 314 
Min 450 140 450 140 
Max 1962 2493 1962 2493 
Range 1512 2353 1512 2353 
M, RM p M p 
Controls PR, R Value Controls PR, R. Value 
T suppressor/Number 11 10 9 8 
cytotoxic Mean 904 1073 0,3786 988 1103 o, 5964 
cells SD 534 607 556 684 
cells/rran3 SEM 161 192 186 242 
Min 248 49 248 49 
Max 1850 2071 1850 2071 
F.ange 1602 2022 1602 2022 
% OKT4 of Number 11 10 9 8 
0KT3 Mean 62 49 0,084'2 60 51 0,3120 
SD 14 20 15 22 
SEM 4 6 5 8 
Min 31 15 31 15 
Max 78 85 78 85 
F.ange 47 70 47 70 
% 0KT8 of Number 11 10 9 8 
0KT3 Mean 48 47 0,8877 50 47 0,6993
SD 14 16 13 17 
SEM 4 5 4 6 
Min 29 15 33 15 
Max 78 70 78 70 
F.ange 49 55 45 55 
Patio 0KT4/ Number 11 10 9 8 
0KT8 Mean 1,43 1, 28 0,2311 1,34 1,38 0,5637 
SD 0,58 0,98 0,56 1,09 
SEM 0,17 0,31 0,19 0,39 
Min 0,40 0,30 0,40 0,30 
Max 2,35 3,89 2,35 3,89 
F.ange 1,95 3,59 1,95 3,59 
M, RM p M p 
Controls PR, R Value Controls PR, R. Value 
% suppressor Number 8 10 7 8 
cell func- Mean 38 16 0,0682 39 19 0,1176 
tion ConA 5 SD 22 27 23 27 
SEM 8 9 9 10 
Min 9 -22 9 -22
Max 76 69 76 69
Range 67 91 67 91
% suppressor Number 10 10 8 8 
cell func- Mean 44 35 0,4055 47 41 0,5995 
tion ConA 30 SD 28 35 31 35 
SEM 9 11 11 12 
Min 14 -11 14 -1
Max 88 92 88 92 
Range 74 103 74 93 
™M (dpm) Number 8 8 8 7 
Mean 6079 4875 0,9164 6079 4951 l,CXX) 
SD 4388 1606 4388 1719 
SEM 1551 568 1551 650 
Min 1418 2072 1418 2072 
Max 14697 6601 14698 6601 
Range 13279 4529 13280 4529 
w:::c Number 11 10 9 8 
X 109/L Mean 7,65 9,29 0,4809 8,08 9,36 o, 7360 
SD 2,81 4,49 2,96 4,86 
SEM 0,85 1,42 0,99 1, 72 
Min 4,70 4,20 4,70 4,20 
Max 14,70 17,70 14,70 17,70 
Range 10,CO 13,50 10,CO 13,50 
M, RM p M p 
Controls PR, R Value Controls PR, R. Value 
% Neufro- Number 11 10 9 8 
phils Mean 51 53 0,6215 so 53 0,5964 
SD 10 13 10 13 
SEM 3 4 3 5 
Min 35 28 35 28 
Max 66 67 66 67 
Range 31 39 31 39 
% Lympho- Number 11 10 9 8 
cytes Mean 40 32 0,1485 40 30 0,1119 
SD 9 12 10 12 
SEM 3 4 3 4 
Min 24 10 24 10 
Max 54 46 54 44 
Range 30 36 30 34 
% .r-bnoc yte s Number 11 10 9 8 
Mean 3 5 0,3905 3 5 0,1701 
SD 2 3 2 4 
SEM 0,58 1 0,62 1 
Min 1 2 1 2 
Max 6 10 6 10 
Range 5 8 5 8 
% :Eosino- Number 11 10 9 8 
phils Mean 6 11 0,4150 6 11 o, 5603 
SD 7 17 7 19 
SEM 2 5 2 6 
Min 0 0 0 0 
Max 21 56 21 56 
Range 21 56 21 56 
M, RM p M 
Controls PR, R Value Controls PR, R. Value 
% Basophils Number 11 10 9 8 
M:an 0,27 0,30 0,6857 0,33 0,38 o, 7176 
SD 0,64 0,95 o, 71 1,06 
SFM 0,19 0,30 0,24 0,38 
Min 0 0 0 0 
Max 2 3 2 3 
Range 2 3 2 3 
% Atypical Number 11 10 9 8 
lymphocites Mean 0,45 0,30 0,6434 0,22 0,375 0,8636 
SD 1,04 0,95 0,67 1,06 
SEM 0,31 0,30 0,22 0,37 
Min 0 0 0 0 
Max 3 3 2 3 
Range 3 3 2 3 
% Others Number 11 10 9 8 
M:an 0 0,10 0,2943 0 0,125 0,2888 
SD 0 0,32 0 0,35 
SFM 0 0,10 0 0,12 
Min 0 0 0 0 
Max 0 1 0 1 
Range 0 1 0 1 
Table 12 long term change in immunological 
parameters among all M:NS patients in remission 
M:NS MCNS 
Remission Remission P Value 
i5 years >5 years
Absolute Nwnber 4 12 
rrononuclears Mean 5255 2988 
cells/mm3 SD 212q 758 0,0393:k 
SEM 2063 218 
Min 3634 1988 
Max 8174 4158 
Range 4540 2170 
Absolute Nwnber 4 12 
lymphocytes Mean 4803 2512 
cells/mm3 SD 2272 705 0,0522 
SEM 1136 203
Min 2976 1716 
Max 7906 3542 
Range 4930 1826 
T cells Number 3 10 
cells/mm3 Mean 4014 1679 
SD 2044 502 0,0180* 
SEM 1180 158 
Min 2344 1065 
Max 6294 2571 
Range 3950 1506 
B cells (Sig) Number 3 10 
cells/mm3 Mean 235 162 
SD 66 171 0,1763
SEM 38 54 
Min 165 0 
Max 297 531 
Range 132 _531 
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Remission Remission P Value 
�5 years >5 years
T suppressor Number 3 11 
cell func- Mean 29 30 
tion ConA 5 SD 20 32 0,9379
SEM 12 9 
Min 6 -2
Max 47 102 
Range 41 104 
T suppressor Number 3 12 
cell func- Mean 32 31 
tion ConA 30 SD 23 18 0,8850 
SEM 13 5 
Min 6 -1
Max 51 57 
Range 45 58 
PWM (dpm) Number 2 7 
Mean 5442 4835 
SD 4011 2160 0,7697 
SEM 2936 816 
Min 2606 500 
Max 8279 7589
Range 5673 7089
vl:C Number 4 12 
X 109/L Mean 10,20 7,20 
SD 3,73 1,23 0,1813 
SEM 1,86 0,35 
Min 6,20 5,20 
Max 13,40 9,40 



























































































Remission Remission P Value 
�5 years >5 years
% Basophils Number 4 12 
Mean 0,25 o,so 
SD 0,50 0,67 o, 5224 
SEM 0,25 0,19 
Min 0 0 
Max 1 2 
Range 1 2 
% Atypical Number 4 12 
Lymphocytes Mean 0 0,33 
SD 0 1,15 o, 5637 
SEM 0 0,33 
Min 0 0 
Max 0 4 
Range 0 4 
% Others Number 4 12 
Mean 0 0 
SD 0 0 
SEM 0 0 
Min 0 0 
Max 0 0 
Range 
Table 13 Corrparison of immunological parameters of all nephrotic syndrome 
patients (regardless of histology and clinical condition) with age, sex and race 
matched controls 
Parameters 

























































All t-ephrotic Syndrome P value 
Patients regardless of 























































































All Nephrotic Syndrome P value 
Patients regardless of 























































































All Nephrotic Syndrome P value 
Patients regardless of 






























% suppressor cell Number 
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All Nephrotic Syndrome P value 
Patients regardless of 






















































































All Nephrotic Syndrome P value 
Patients regardless of 
Histology or condition 
64 
51 
13 0,9975 
2 
22 
92 
70 
64 
36 
12 0,0499* 
2 
5 
63 
58 
64 
5 
3 0,(XX)J* 
0,38 
1 
13 
12 
64 
6 
9 0,1366 
1 
0 
56 
56 
ue 
,2 
32 
34 
